{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Topology cross-checking","Modularity cross-checking","Cross-checking references"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Topology cross-checking","index":0,"n_rows":306,"n_cols":6,"rows_kept":306,"flags":["formulas_cached_only"]}
["Community","General description ","No of drugs","Exceptions explained by  property ","Non-explained","Legend:"]
["I","Immune system related drugs",80,"Aciclovir L1, L2","Chlorzoxazone ","D - drugs.com"]
[{"$nulls":3},"Adefovir dipivoxil L3, L4","Lamivudine ","R - rxlist.com"]
[{"$nulls":3},"Adenosine L5, L6","Trimethadione ","Lx - literature reference no. x from sheet \"Cross-checking references\""]
[{"$nulls":3},"Aminophylline L7, L8",null,"DB43 - DrugBank 4.3"]
[{"$nulls":3},"Dipyridamole L9"]
[{"$nulls":3},"Dyphylline L7, L8"]
[{"$nulls":3},"Halothane L10, L11"]
[{"$nulls":3},"Mexiletine L12, L13"]
[{"$nulls":3},"Oxtriphylline L7, L8"]
[{"$nulls":3},"Regadenoson L14"]
[{"$nulls":3},"Telbivudine L15, L16, L17"]
[{"$nulls":3},"Temazepam L18, L19"]
[{"$nulls":3},"Theophylline L7, L20, L21"]
[{"$nulls":3},"Valganciclovir L22, L23"]
[{"$nulls":3},"Zileuton L24, L305, L306"]
[null,null,"[%]",18.75,3.75]
["II","Cytochromes P450 ",271,"Abacavir D; R; L25","Alteplase "]
[null,"substrates/inhibitors/ inducers",null,"Cabozatinib DB43","Alvimopan "]
[{"$nulls":3},"Clocortolone L26, L27, L28","Bevacizumab "]
[{"$nulls":3},"Deferoxamine L29","Butorphanol "]
[{"$nulls":3},"Degarelix R; L30, L31","Cefditoren "]
[{"$nulls":3},"Epirubicin L32, L33","Cilastatin "]
[{"$nulls":3},"Fusidic acid L34","Cinolazepam "]
[{"$nulls":3},"Heroin L35","Dabigatran etexilate "]
[{"$nulls":3},"Kava L36, L37","Dapiprazole "]
[{"$nulls":3},"Levomilnacipran DB43","Dextromoramide "]
[{"$nulls":3},"Mitomycin C L38, L39","Dezocine "]
[{"$nulls":3},"Nalbuphine L40, L41","Didanosine "]
[{"$nulls":3},"Oxaliplatin DB43","Dipipanone "]
[{"$nulls":3},"Papaverine L42","Fidaxomicin "]
[{"$nulls":3},"Pentazocine L43","Filgrastim "]
[{"$nulls":3},"Progesterone DB43","Gadoxetate "]
[{"$nulls":3},"Pyrazinamide DB43","Ganciclovir "]
[{"$nulls":3},"Ribavirin DB43","Glucarpidase "]
[{"$nulls":3},"Vigabatrin D; R","Halazepam "]
[{"$nulls":3},"Vitamin C L44, L45, L46","Interferon beta-1b "]
[{"$nulls":3},"Vitamin E D; L44, L46, L47, L48, L49","Imipenem "]
[{"$nulls":4},"Iohexol"]
[{"$nulls":4},"Leucovorin "]
[{"$nulls":4},"Lorazepam "]
[{"$nulls":4},"Mipomersen "]
[{"$nulls":4},"Nizatidine"]
[{"$nulls":4},"Pasireotide "]
[{"$nulls":4},"Phentolamine"]
[{"$nulls":4},"Ribavirin monophosphate"]
[{"$nulls":4},"Stavudine "]
[{"$nulls":4},"Streptokinase "]
[{"$nulls":4},"Sodium bicarbonate "]
[{"$nulls":4},"Tolazoline "]
[{"$nulls":4},"Valrubicin "]
[null,null,"[%]",{"v":7.7490774907749085,"d":"7.75"},{"v":12.546125461254611,"d":"12.55"}]
["III","Nervous System acting drugs",307,"Altretamine D; R","Abarelix "]
[{"$nulls":3},"Arsenic trioxide L50, L51","Apramycin "]
[{"$nulls":3},"Artemether-lumefantrine D; R","Benzylpenicilloyl polylysine"]
[{"$nulls":3},"Azithromycin L52","Bepridil"]
[{"$nulls":3},"Bezafibrate L53, L54","Digoxin immune fab "]
[{"$nulls":3},"Chloroquine D; R","Oprelvekin "]
[{"$nulls":3},"Dacarbazine L55, L56","Perflutren "]
[{"$nulls":3},"Dasatinib D; L57","Potassium chloride "]
[{"$nulls":3},"Desmopressin L58","Telavancin "]
[{"$nulls":3},"Dofetilide L59, L60","Troleandomycin "]
[{"$nulls":3},"Encainide L61, L62","Tryptophanyl-5’amp "]
[{"$nulls":3},"Flecainide L62, L63"]
[{"$nulls":3},"Foscarnet L64, L65"]
[{"$nulls":3},"Gadofosveset trisodium L66"]
[{"$nulls":3},"Gatifloxacin D; L67, L68, L69, L70"]
[{"$nulls":3},"Grepafloxacin L67, L68"]
[{"$nulls":3},"Halofantrine D"]
[{"$nulls":3},"Hydroxychloroquine D; R"]
[{"$nulls":3},"Indapamide L71, L72"]
[{"$nulls":3},"Isradipine L73, L74"]
[{"$nulls":3},"Lapatinib L75, L76"]
[{"$nulls":3},"Levofloxacin D; L67, L68, L69, L70"]
[{"$nulls":3},"Mibefradil L77, L78, L79"]
[{"$nulls":3},"Nilotinib D"]
[{"$nulls":3},"Norfloxacin D; L67, L68, L69, L80"]
[{"$nulls":3},"Octreotide L81, L82, L83"]
[{"$nulls":3},"Oxytocin L84, L85, L86"]
[{"$nulls":3},"Pramlintide L87"]
[{"$nulls":3},"Primaquine D; R; L88"]
[{"$nulls":3},"Probucol L89"]
[{"$nulls":3},"Proguanil D; R"]
[{"$nulls":3},"Pyrimethamine L90, L91"]
[{"$nulls":3},"Sparfloxacin D; L67, L68, L69, L70"]
[{"$nulls":3},"Tacrolimus L92, L93, L94"]
[{"$nulls":3},"Terbinafine D; R"]
[{"$nulls":3},"Toremifene L95"]
[{"$nulls":3},"Tripelennamine L96, L97"]
[{"$nulls":3},"Vorinostat L98, L99, L100"]
[null,null,"[%]",{"v":12.37785016286645,"d":"12.38"},{"v":3.5830618892508146,"d":"3.58"}]
["IV","Sympathetic Nervous System ",81,"Acarbose L101, L102","Acetohexamide "]
[null,"acting drugs",null,"Amyl nitrite L103, L104","Clofibrate "]
[{"$nulls":3},"Avanafil L105, L106","Cloramfenicol "]
[{"$nulls":3},"Erythrityl tetranitrate L104","Clorpropamide "]
[{"$nulls":3},"Insulin aspart L107, L295, L296","Gliclazide "]
[{"$nulls":3},"Insulin detemir D; L295, L296","Glicodiazine "]
[{"$nulls":3},"Insulin glargine D; L295, L296","Glipizide "]
[{"$nulls":3},"Insulin glulisine D; L295, L296","Glisoxepide "]
[{"$nulls":3},"Insulin lispro D; L295, L296","Glucosamine "]
[{"$nulls":3},"Isoflurane L108","Ibuprofen "]
[{"$nulls":3},"Lidocaine L109, L110, L111","Indometacin "]
[{"$nulls":3},"Metformin L112","Lorcaserin "]
[{"$nulls":3},"Miglitol L113","Methacholine "]
[{"$nulls":3},"Nitroglycerin L104","Montelukast "]
[{"$nulls":3},"Pargyline DB43","Nateglinide "]
[{"$nulls":3},"Sitagliptin L114, L115","Phenylbutazone "]
[{"$nulls":3},"Sulfinpyrazone L116, L117","Pipobroman "]
[{"$nulls":3},"Tolbutamide L118, L119","Repaglinide "]
[{"$nulls":4},"Somatropin recombinant "]
[{"$nulls":4},"Sulfamethazine "]
[{"$nulls":4},"Tolazamide "]
[{"$nulls":4},"Triflusal "]
[null,null,"[%]",{"v":22.22222222222222,"d":"22.22"},{"v":27.160493827160494,"d":"27.16"}]
["V","Kalemia and",54,"Aliskiren L300","Lithium "]
[null,"platelet activity ",null,"Benazepril L120, L121","Nesiritide "]
[null,"related drugs",null,"Candesartan L123"]
[{"$nulls":3},"Captopril L120, L121, L122"]
[{"$nulls":3},"Chlorthalidone L125"]
[{"$nulls":3},"Cilazapril L120, L121"]
[{"$nulls":3},"Clevidipine L126, L127"]
[{"$nulls":3},"Cyclandelate L128"]
[{"$nulls":3},"Digoxin L129, L130"]
[{"$nulls":3},"Enalapril L120, L121, L122"]
[{"$nulls":3},"Eprosartan L123"]
[{"$nulls":3},"Forasartan L123"]
[{"$nulls":3},"Fosinopril L120, L121"]
[{"$nulls":3},"Hydrochlorothiazide L131"]
[{"$nulls":3},"Icatibant L122, L133"]
[{"$nulls":3},"Levobunolol L134"]
[{"$nulls":3},"Lisinopril L120, L121"]
[{"$nulls":3},"Losartan L123, L124"]
[{"$nulls":3},"Mannitol L135, L136, L137"]
[{"$nulls":3},"Metipranolol L134"]
[{"$nulls":3},"Minoxidil L147"]
[{"$nulls":3},"Moexipril L120, L121"]
[{"$nulls":3},"Nitroprusside L138, L139, L140"]
[{"$nulls":3},"Perindopril L120, L121"]
[{"$nulls":3},"Potassium L141, L142"]
[{"$nulls":3},"Propofol D; L143, L144"]
[{"$nulls":3},"Ramipril L120, L121, L122"]
[{"$nulls":3},"Quinapril L120, L121"]
[{"$nulls":3},"Saprisartan L123"]
[{"$nulls":3},"Spirapril L120, L121"]
[{"$nulls":3},"Tasosartan L123"]
[{"$nulls":3},"Tizanidine L283"]
[{"$nulls":3},"Urea L145, L146"]
[{"$nulls":3},"Valsartan L123"]
[null,null,"[%]",{"v":62.96296296296296,"d":"62.96"},{"v":3.7037037037037033,"d":"3.70"}]
["VI","Hemostasis related drugs",125,"Acetaminophen L219","Allopurinol "]
[{"$nulls":3},"Alendronate L220","Aminoglutethimide "]
[{"$nulls":3},"Alfacalcidol L148, L149, L150, L151, L152","Bromfenac "]
[{"$nulls":3},"Aluminium hydroxide L153, L154","Cyclophosphamide"]
[{"$nulls":3},"Amifostine L155","Deslanoside "]
[{"$nulls":3},"Azilsartan medoxomil L123","Dextrothyroxine "]
[{"$nulls":3},"Bumetanide L158","Diazoxide "]
[{"$nulls":3},"Calcipotriol L148, L149, L150, L151, L152","Dichlorphenamide"]
[{"$nulls":3},"Celecoxib DB43","Difluprednate "]
[{"$nulls":3},"Chenodeoxycholic acid L221","Digitoxin "]
[{"$nulls":3},"Cholecalciferol L148, L149, L150, L151, L152","Ethacrynic acid "]
[{"$nulls":3},"Cholestyramine L222","Ethchlorvynol "]
[{"$nulls":3},"Colesevelam L159, L160","Etoricoxib "]
[{"$nulls":3},"Colestipol D","Exenatide "]
[{"$nulls":3},"Danazol L223","Levamisole "]
[{"$nulls":3},"Ergocalciferol L148, L149, L150, L151, L152","Liraglutide "]
[{"$nulls":3},"Ezetimibe L224","Lumiracoxib "]
[{"$nulls":3},"Fluoxymesterone D","Nalidixic acid "]
[{"$nulls":3},"Fluvastatin L225, L226","Orlistat "]
[{"$nulls":3},"Furosemide L161","Oxyphenbutazone "]
[{"$nulls":3},"Gemcitabine D","Palifermin "]
[{"$nulls":3},"Insulin regular L162","Pemetrexed "]
[{"$nulls":3},"Levothyroxine L291, L292, L293, L294","Pralatrexate "]
[{"$nulls":3},"Liothyronine L291, L292, L293, L294","Propoxyphene "]
[{"$nulls":3},"Liotrix L291, L292, L293, L294","Sulfacytine "]
[{"$nulls":3},"Memantine L163","Sulfadimethoxine "]
[{"$nulls":3},"Methimazole D","Sulfadoxine "]
[{"$nulls":3},"Methotrexate L227","Sulfapyridine "]
[{"$nulls":3},"Mitotane L228","Sulfathiazole "]
[{"$nulls":3},"Nandrolone decanoate D","Testolactone "]
[{"$nulls":3},"Nandrolone  phenpropionate D","Thyroglobulin "]
[{"$nulls":3},"Nepafenac L164","Torasemide "]
[{"$nulls":3},"Norelgestromin L165, L166","Trichlormethiazide "]
[{"$nulls":3},"Olmesartan L123"]
[{"$nulls":3},"Oxandrolone D"]
[{"$nulls":3},"Paricalcitol L167"]
[{"$nulls":3},"Propylthiouracil D"]
[{"$nulls":3},"Rituximab L168, L169"]
[{"$nulls":3},"Selenium sulfide L170"]
[{"$nulls":3},"Sulfamerazine DB43"]
[{"$nulls":3},"Sulfamethoxazole DB43"]
[{"$nulls":3},"Telmisartan L123"]
[{"$nulls":3},"Testosterone D"]
[{"$nulls":3},"Testosterone propionate D"]
[{"$nulls":3},"Tenoxicam L229"]
[{"$nulls":3},"Tigecycline L230"]
[{"$nulls":3},"Trandolapril L120, L121"]
[{"$nulls":3},"Trimetrexate D"]
[null,null,"[%]",{"v":38.4,"d":"38.40"},{"v":26.400000000000002,"d":"26.40"}]
["VII","Neuromuscular transmission",58,"Amikacin L69, L171, L172, L173","Amphotericin B "]
[null,"acting drugs",null,"Azathioprine L297, L298","Attapulgite","Azathioprine DB 4.3 - immunosuppressive drug"]
[{"$nulls":3},"Clindamycin L69, L174, L175","Cefaclor "]
[{"$nulls":3},"Gallium nitrate D","Cefadroxil "]
[{"$nulls":3},"Gentamicin L69, L171, L172, L173","Cefalotin "]
[{"$nulls":3},"Kanamycin L69, L171, L172, L173","Cefamandole "]
[{"$nulls":3},"Lincomycin L69, L174, L175","Cefazolin "]
[{"$nulls":3},"Mercaptopurine L299","Cefixime "]
[{"$nulls":3},"Mesalazine D; R","Cefmetazole "]
[{"$nulls":3},"Neomycin L69, L171, L172, L173","Cefonicid "]
[{"$nulls":3},"Netilmicin L69, L171, L172, L173","Cefoperazone "]
[{"$nulls":3},"Olsalazine D; R","Ceforanide "]
[{"$nulls":3},"Streptomycin L171, L172, L173","Cefotaxime "]
[{"$nulls":3},"Sulfasalazine D; R","Cefotetan "]
[{"$nulls":3},"Thioguanine L299","Cefoxitin "]
[{"$nulls":3},"Ticarcillin D","Cefprozil "]
[{"$nulls":3},"Tobramycin L69, L171, L172, L173","Cefradine "]
[{"$nulls":3},"Vancomycin L176, L177","Ceftizoxime "]
[{"$nulls":4},"Ceftriaxone"]
[{"$nulls":4},"Cefuroxime "]
[{"$nulls":4},"Cephalexin "]
[{"$nulls":4},"Cephaloglycin "]
[{"$nulls":4},"Cephapirin "]
[{"$nulls":4},"Loracarbef "]
[{"$nulls":4},"Moxalactam "]
[null,null,"[%]",{"v":31.03448275862069,"d":"31.03"},{"v":43.103448275862064,"d":"43.10"}]
["VIII","Metal cations complexes",69,"Amoxicillin L301","Acitretin "]
[{"$nulls":3},"Ampicillin L301","Azlocillin "]
[{"$nulls":3},"Mycophenolate mofetil DB43; D; L307, L308 ","Aztreonam "]
[{"$nulls":3},"Penicillin G L301","Bacampicillin "]
[{"$nulls":3},"Penicillin V L301","Carbenicillin "]
[{"$nulls":3},"Rolitetracycline L178","Clavulanate "]
[{"$nulls":4},"Cloxacillin "]
[{"$nulls":4},"Cyclacillin "]
[{"$nulls":4},"Dicloxacillin "]
[{"$nulls":4},"Etretinate "]
[{"$nulls":4},"Flucloxacillin "]
[{"$nulls":4},"Isotretinoin "]
[{"$nulls":4},"Kaolin "]
[{"$nulls":4},"Mestranol "]
[{"$nulls":4},"Methicillin acyl-serine "]
[{"$nulls":4},"Methoxyflurane "]
[{"$nulls":4},"Meticillin "]
[{"$nulls":4},"Mezlocillin "]
[{"$nulls":4},"Oxacillin "]
[{"$nulls":4},"Penciclovir "]
[{"$nulls":4},"Piperacillin "]
[{"$nulls":4},"Pivampicillin "]
[{"$nulls":4},"Pivmecillinam "]
[{"$nulls":4},"Tazobactam "]
[null,null,"[%]",{"v":8.695652173913043,"d":"8.70"},{"v":34.78260869565217,"d":"34.78"}]
["IX","Epilepsy related drugs",96,"Betamethasone L179, L180","Ambenonium "]
[{"$nulls":3},"Bexarotene L181","Belatacept "]
[{"$nulls":3},"Bismuth subsalicylate D; L182","Belimumab "]
[{"$nulls":3},"Brinzolamide L183, L184","Denosumab "]
[{"$nulls":3},"Capecitabine D; R","Gefitinib "]
[{"$nulls":3},"Chlorotrianisene L185, L186, L187, L188","Griseofulvin "]
[{"$nulls":3},"Cisplatin L189, L190, L191","Melatonin "]
[{"$nulls":3},"Clomifene R","Methoxsalen "]
[{"$nulls":3},"Conjugated estrogens L185, L186, L187, L188","Sulfamethizole "]
[{"$nulls":3},"Cortisone acetate L179, L180","Trioxsalen "]
[{"$nulls":3},"Desogestrel L187, L192, L193","Troglitazone "]
[{"$nulls":3},"Dexamethasone L179, L180","Vecuronium "]
[{"$nulls":3},"Diethylstilbestrol L185, L186, L187, L188"]
[{"$nulls":3},"Disulfiram D"]
[{"$nulls":3},"Dorzolamide L183, L184"]
[{"$nulls":3},"Edrophonium R; L194"]
[{"$nulls":3},"Estriol L185, L186, L187, L188"]
[{"$nulls":3},"Estrone L185, L186, L187, L188"]
[{"$nulls":3},"Ethynodiol diacetate L187, L192, L193"]
[{"$nulls":3},"Ethinyl estradiol L185, L186, L187, L188"]
[{"$nulls":3},"Etonogestrel L187, L192, L193"]
[{"$nulls":3},"Felodipine L195"]
[{"$nulls":3},"Fludrocortisone R"]
[{"$nulls":3},"Fluorouracil D"]
[{"$nulls":3},"Folic acid D; L196"]
[{"$nulls":3},"Glycerol phenylbutyrate D; R"]
[{"$nulls":3},"Hydrocortisone L179, L180"]
[{"$nulls":3},"Levonorgestrel L187, L192, L193"]
[{"$nulls":3},"Magnesium salicylate D"]
[{"$nulls":3},"Mebendazole L197"]
[{"$nulls":3},"Medroxyprogesterone L187, L192, L193"]
[{"$nulls":3},"Megestrol L187, L192, L193"]
[{"$nulls":3},"Methadone D; L198"]
[{"$nulls":3},"Methazolamide L183"]
[{"$nulls":3},"Metronidazole D"]
[{"$nulls":3},"Metyrapone L199"]
[{"$nulls":3},"Neostigmine D"]
[{"$nulls":3},"Nifedipine L200, L201, L304"]
[{"$nulls":3},"Norethindrone L187, L192, L193"]
[{"$nulls":3},"Norgestimate L187, L192, L193"]
[{"$nulls":3},"Paramethasone L179, L180"]
[{"$nulls":3},"Polymyxin B sulfate L69"]
[{"$nulls":3},"Prednisolone L179, L180"]
[{"$nulls":3},"Prednisone L179, L180"]
[{"$nulls":3},"Pyridostigmine L202"]
[{"$nulls":3},"Raloxifene L203"]
[{"$nulls":3},"Salicylate sodium D"]
[{"$nulls":3},"Salsalate D"]
[{"$nulls":3},"Quinestrol L185, L186, L187, L188"]
[{"$nulls":3},"Thiotepa L204"]
[{"$nulls":3},"Tretinoin D; L205"]
[{"$nulls":3},"Triamcinolone L179, L180"]
[{"$nulls":3},"Trisalicylate choline D"]
[{"$nulls":3},"Ursodeoxycholic acid L206, L207"]
[{"$nulls":3},"Vitamin A D; L205"]
[null,null,"[%]",{"v":57.291666666666664,"d":"57.29"},{"v":12.5,"d":"12.50"}]
["TOTAL",1141,"[%]",{"v":22.085889570552148,"d":"22.09"},{"v":15.775635407537248,"d":"15.78"}]

{"sheet":"Modularity cross-checking","index":1,"n_rows":265,"n_cols":7,"rows_kept":265,"flags":["formulas_cached_only"]}
["Modularity class"," Code","No of drugs","Genaral description ","Exceptions expalined by other databases or literature","Not-explained ","Legend:"]
["Light blue","LB",156,"Antineoplastic and immunomodulatory","Aciclovir L1, L2","Attapulgite ","D - drugs.com"]
[{"$nulls":3},"properties, rheumatoid arthritis related ","Adefovir dipivoxil L3, L4","Cefalotin ","R - rxlist.com"]
[{"$nulls":3},"drugs, musculoskeletal acting drugs","Adenosine L5, L6","Cefamandole ","Lx - literature reference no. x from sheet \"Cross-checking references\""]
[{"$nulls":4},"Amphotericin B D; R","Cefixime ","D43 - DrugBank 4.3"]
[{"$nulls":4},"Amikacin L69, L171, L172, L173","Cefmetazole "]
[{"$nulls":4},"Aminophylline L7, L8","Cefonicid "]
[{"$nulls":4},"Caffeine L208","Cefoperazone "]
[{"$nulls":4},"Cefaclor L303","Ceforanide "]
[{"$nulls":4},"Cefazolin D","Cefotaxime "]
[{"$nulls":4},"Ceftriaxone L302","Cefotetan "]
[{"$nulls":4},"Cilastatin L209","Cephaloglycin "]
[{"$nulls":4},"Clindamycin L69, L174, L175","Cephapirin "]
[{"$nulls":4},"Dipyridamole L9","Glycerol phenylbutyrate "]
[{"$nulls":4},"Dyphylline L7, L8","Kaolin "]
[{"$nulls":4},"Gallium nitrate D","Loracarbef "]
[{"$nulls":4},"Gentamicin L69, L171, L172, L173","Moxalactam derivative "]
[{"$nulls":4},"Guanabenz L210","Penciclovir "]
[{"$nulls":4},"Halothane L10, L11","Thiabendazole "]
[{"$nulls":4},"Imipenem L211","Troleandomycin "]
[{"$nulls":4},"Kanamycin L69, L171, L172, L173"]
[{"$nulls":4},"Lincomycin L69, L174, L175"]
[{"$nulls":4},"Mesalazine D; R"]
[{"$nulls":4},"Neomycin L69, L171, L172, L173"]
[{"$nulls":4},"Netilmicin L69, L171, L172, L173"]
[{"$nulls":4},"Olsalazine D; R"]
[{"$nulls":4},"Oxtriphylline L7, L8"]
[{"$nulls":4},"Pefloxacin L212, L213"]
[{"$nulls":4},"Pentoxifylline L214"]
[{"$nulls":4},"Ramelteon L215, L216"]
[{"$nulls":4},"Regadenoson L14"]
[{"$nulls":4},"Streptomycin L69, L171, L172, L173"]
[{"$nulls":4},"Sulfasalazine D; R"]
[{"$nulls":4},"Telbivudine L15, L16, L17"]
[{"$nulls":4},"Temazepam L18, L19"]
[{"$nulls":4},"Theophylline L7, L20, L21"]
[{"$nulls":4},"Ticarcillin D"]
[{"$nulls":4},"Tobramycin L69, L171, L172, L173"]
[{"$nulls":4},"Vancomycin L176, L177"]
[{"$nulls":4},"Zileuton L24, L305, L306"]
[{"$nulls":3},"[%]",{"v":25,"d":"25.00"},{"v":12.179487179487179,"d":"12.18"}]
["Dark blue","DB",232,"Central and peripheral nervous system","Arsenic trioxide L50, L51","Abarelix "]
[{"$nulls":3}," acting drugs","Artemether-lumefantrine D; R","Apramycin "]
[{"$nulls":4},"Azithromycin L52","Bepridil "]
[{"$nulls":4},"Chloroquine D,R","Benzylpenicilloyl polylysine"]
[{"$nulls":4},"Dasatinib D; L57","Digoxin immune fab"]
[{"$nulls":4},"Desmopressin L58","Mipomersen "]
[{"$nulls":4},"Dofetilide L59, L60","Oprelvekin "]
[{"$nulls":4},"Encainide L61, L62","Potassium chloride "]
[{"$nulls":4},"Flecainide L62, L63","Telavancin"]
[{"$nulls":4},"Foscarnet L64, L65","Perflutren"]
[{"$nulls":4},"Gadofosveset trisodium L66"]
[{"$nulls":4},"Gatifloxacin D; L67, L68, L69, L70"]
[{"$nulls":4},"Grepafloxacin L67, L68"]
[{"$nulls":4},"Halofantrine D"]
[{"$nulls":4},"Hydroxychloroquine D; R"]
[{"$nulls":4},"Indapamide L71, L72"]
[{"$nulls":4},"Isradipine L73, L74"]
[{"$nulls":4},"Lapatinib L75, L76"]
[{"$nulls":4},"Levofloxacin D; L67, L68, L69, L70"]
[{"$nulls":4},"Mibefradil L77, L78, L79"]
[{"$nulls":4},"Nilotinib D"]
[{"$nulls":4},"Norfloxacin D; L67, L68, L69, L80"]
[{"$nulls":4},"Octreotide L81, L82, L83"]
[{"$nulls":4},"Papaverine L217"]
[{"$nulls":4},"Pramlintide L87"]
[{"$nulls":4},"Primaquine D; R; L88"]
[{"$nulls":4},"Probucol L89"]
[{"$nulls":4},"Proguanil D; R"]
[{"$nulls":4},"Pyrimethamine L90, L91"]
[{"$nulls":4},"Sparfloxacin D; L67, L68, L69, L70"]
[{"$nulls":4},"Tacrolimus L92, L93, L94"]
[{"$nulls":4},"Tocainide D; R; L218"]
[{"$nulls":4},"Toremifene L95"]
[{"$nulls":4},"Tripelennamine L96, L97"]
[{"$nulls":4},"Vorinostat L98, L99, L100"]
[{"$nulls":3},"[%]",{"v":15.086206896551724,"d":"15.09"},{"v":4.310344827586207,"d":"4.31"}]
["Velvet  ","VM",210,"Substrates, inhibitors and inducers ","Abacavir D; R; L25","Bevacizumab "]
["maroon",null,null,"of specific CYP enzymes","Cabozatinib DB43","Cefditoren "]
[{"$nulls":4},"Clocortolone L26, L27, L28","Cinolazepam "]
[{"$nulls":4},"Deferoxamine L29","Dabigatran etexilate "]
[{"$nulls":4},"Fusidic acid L34","Dapiprazole "]
[{"$nulls":4},"Kava L36, L37","Didanosine "]
[{"$nulls":4},"Levomilnacipran DB43","Filgrastim "]
[{"$nulls":4},"Mitomycin C L38, L39","Gadoxetate "]
[{"$nulls":4},"Progesterone DB43","Ganciclovir "]
[{"$nulls":4},"Ribavirin DB43","Halazepam "]
[{"$nulls":4},"Vitamin C L44, L45, L46","Interferon beta-1b "]
[{"$nulls":5},"Iohexol "]
[{"$nulls":5},"Lorazepam "]
[{"$nulls":5},"Nizatidine "]
[{"$nulls":5},"Phentolamine "]
[{"$nulls":5},"Ribavirin monophosphate "]
[{"$nulls":5},"Stavudine "]
[{"$nulls":5},"Tolazoline "]
[{"$nulls":5},"Valrubicin "]
[{"$nulls":3},"[%]",{"v":5.238095238095238,"d":"5.24"},{"v":9.047619047619047,"d":"9.05"}]
["Green","G",191,"Drugs that interfere in different phases ","Acetaminophen L219","Ambenonium "]
[{"$nulls":3},"of hemostasis, anticonvulsant and ","Allopurinol L231, L232","Canagliflozin "]
[{"$nulls":3},"epileptogenic drugs","Amoxicillin L69, L205","Demeclocycline "]
[{"$nulls":4},"Ampicillin L69, L205","Dextrothyroxine"]
[{"$nulls":4},"Azlocillin L69, L205","Dicloxacillin "]
[{"$nulls":4},"Aztreonam L69, L205","Etretinate "]
[{"$nulls":4},"Bacampicillin L69, L205","Gefitinib"]
[{"$nulls":4},"Betamethasone L179, L180","Griseofulvin "]
[{"$nulls":4},"Bexarotene L181","Melatonin "]
[{"$nulls":4},"Bismuth subsalicylate D; L182","Metacycline "]
[{"$nulls":4},"Bosentan L233","Methoxsalen "]
[{"$nulls":4},"Brinzolamide L183, L184","Orlistat "]
[{"$nulls":4},"Capecitabine D; R","Oxytetracycline "]
[{"$nulls":4},"Carbenicillin L69, L205","Propylthiouracil"]
[{"$nulls":4},"Chlorotrianisene L185, L186, L187, L188","Pyrazinamide "]
[{"$nulls":4},"Clavulanate L69, L205","Sulfacytine "]
[{"$nulls":4},"Clomifene R","Sulfadimethoxine "]
[{"$nulls":4},"Cloxacillin L69, L205","Sulfadoxine "]
[{"$nulls":4},"Colestipol D","Sulfamerazine "]
[{"$nulls":4},"Conjugated estrogens L185, L186, L187, L188","Sulfamethazine "]
[{"$nulls":4},"Cortisone acetate L179, L180","Sulfamethizole"]
[{"$nulls":4},"Cholestyramine L222","Sulfamethoxazole "]
[{"$nulls":4},"Cyclacillin L69, L205","Sulfapyridine "]
[{"$nulls":4},"Cyclophosphamide L234","Sulfathiazole "]
[{"$nulls":4},"Cyclosporine D","Trioxsalen "]
[{"$nulls":4},"Danazol L223","Thyroglobulin "]
[{"$nulls":4},"Desogestrel L187, L192, L193","Troglitazone "]
[{"$nulls":4},"Dexamethasone L179, L180","Vecuronium "]
[{"$nulls":4},"Diethylstilbestrol L185, L186, L187, L188"]
[{"$nulls":4},"Disulfiram D; L309"]
[{"$nulls":4},"Dorzolamide L183, L184"]
[{"$nulls":4},"Doxycycline L245"]
[{"$nulls":4},"Estradiol valerate/dienogest D"]
[{"$nulls":4},"Estriol L185, L186, L187, L188"]
[{"$nulls":4},"Estrone L185, L186, L187, L188"]
[{"$nulls":4},"Ethinyl estradiol L185,1 L86, L187, L188"]
[{"$nulls":4},"Ethynodiol diacetate L187, L192, L193"]
[{"$nulls":4},"Etonogestrel L187, L192, L193"]
[{"$nulls":4},"Ezetimibe L224"]
[{"$nulls":4},"Fenofibrate L235"]
[{"$nulls":4},"Fidaxomicin L236"]
[{"$nulls":4},"Flucloxacillin L69, L205"]
[{"$nulls":4},"Fludrocortisone R"]
[{"$nulls":4},"Fluorouracil D"]
[{"$nulls":4},"Fluoxymesterone D"]
[{"$nulls":4},"Fluvastatin L225, L226"]
[{"$nulls":4},"Folic acid D; L196"]
[{"$nulls":4},"Gemcitabine D"]
[{"$nulls":4},"Gemfibrozil L237"]
[{"$nulls":4},"Hetacillin L69, L205"]
[{"$nulls":4},"Hydrocortisone L179, L180"]
[{"$nulls":4},"Isotretinoin L205"]
[{"$nulls":4},"Levamisole L238"]
[{"$nulls":4},"Levonorgestrel L187, L192, L193"]
[{"$nulls":4},"Liothyronine L291, L292, L293, L294"]
[{"$nulls":4},"Liotrix L291, L292, L293, L294"]
[{"$nulls":4},"Magnesium salicylate D"]
[{"$nulls":4},"Medroxyprogesterone L187, L192, L193"]
[{"$nulls":4},"Megestrol L193"]
[{"$nulls":4},"Mestranol D"]
[{"$nulls":4},"Methazolamide L183"]
[{"$nulls":4},"Methoxyflurane DB43"]
[{"$nulls":4},"Meticillin L69, L205"]
[{"$nulls":4},"Methadone D; L198"]
[{"$nulls":4},"Methicillin acyl-serine "]
[{"$nulls":4},"Methimazole D"]
[{"$nulls":4},"Methotrexate L227"]
[{"$nulls":4},"Metronidazole D"]
[{"$nulls":4},"Metyrapone L199"]
[{"$nulls":4},"Mezlocillin L69, L205"]
[{"$nulls":4},"Minocycline L245"]
[{"$nulls":4},"Mitotane L228"]
[{"$nulls":4},"Nafcillin D; R; L239"]
[{"$nulls":4},"Nandrolone decanoate D"]
[{"$nulls":4},"Nandrolone  phenpropionate D"]
[{"$nulls":4},"Neostigmine D"]
[{"$nulls":4},"Norethindrone L187, L192, L193"]
[{"$nulls":4},"Oxacillin L69, L205"]
[{"$nulls":4},"Oxandrolone D"]
[{"$nulls":4},"Paramethasone L179, L180"]
[{"$nulls":4},"Penicillin G L69, L205"]
[{"$nulls":4},"Penicillin V L69, L205"]
[{"$nulls":4},"Piperacillin L69, L205, L246"]
[{"$nulls":4},"Pivampicillin L69, L205"]
[{"$nulls":4},"Pivmecillinam L69, L205"]
[{"$nulls":4},"Polymyxin B sulfate L69"]
[{"$nulls":4},"Pravastatin L240, L241"]
[{"$nulls":4},"Prednisolone L179, L180"]
[{"$nulls":4},"Prednisone L179, L180"]
[{"$nulls":4},"Propylthiouracil D"]
[{"$nulls":4},"Quinestrol L185, L186, L187, L188"]
[{"$nulls":4},"Raloxifene L203"]
[{"$nulls":4},"Rosiglitazone L242"]
[{"$nulls":4},"Rosuvastatin L243"]
[{"$nulls":4},"Salicylate sodium D"]
[{"$nulls":4},"Sulfinpyrazone D"]
[{"$nulls":4},"Tazobactam L69, L205, L246"]
[{"$nulls":4},"Tenoxicam L229"]
[{"$nulls":4},"Testolactone L247"]
[{"$nulls":4},"Testosterone D"]
[{"$nulls":4},"Testosterone propionate D"]
[{"$nulls":4},"Tetracycline L245"]
[{"$nulls":4},"Thiotepa L204"]
[{"$nulls":4},"Tigecycline L230"]
[{"$nulls":4},"Tretinoin D;L205"]
[{"$nulls":4},"Triamcinolone L179, L180"]
[{"$nulls":4},"Trisalicylate choline D"]
[{"$nulls":4},"Vandetanib L244"]
[{"$nulls":4},"Vitamin A D; L205"]
[{"$nulls":4},"Vitamin E L248, L249"]
[{"$nulls":3},"[%]",{"v":57.59162303664922,"d":"57.59"},{"v":14.659685863874344,"d":"14.66"}]
["Magenta","M",166,"Drugs acting on sympathetic nervous","Exenatide L250","Altretamine "]
[{"$nulls":3}," system","Isosorbide dinitrate L251, L252","Bezafibrate "]
[{"$nulls":4},"Mifepristone L253","Buprenorphine "]
[{"$nulls":4},"Oxycodone L254","Caspofungin "]
[{"$nulls":4},"Oxytocin L255","Degarelix "]
[{"$nulls":4},"Pioglitazone L256, L257, L258","Dextromethorphan "]
[{"$nulls":4},"Ropivacaine L259","Glimepiride "]
[{"$nulls":4},"S-Adenosylmethionine L260","Pasireotide "]
[{"$nulls":4},"Trazodone L261, L262","Terbinafine"]
[{"$nulls":4},"Udenafil L263","Tramadol "]
[{"$nulls":5},"Tryptophanyl-5’amp "]
[{"$nulls":3},"[%]",{"v":6.024096385542169,"d":"6.02"},{"v":6.626506024096386,"d":"6.63"}]
["Golden ","GB",155,"Drugs interfering with platelets activity ","Alendronate L220","Bromfenac "]
["brown",null,null,"and plasma potassium levels","Alfacalcidol L148, L149, L150, L151, L152","Dichlorphenamide "]
[{"$nulls":4},"Aluminium hydroxide L153, L154","Difluprednate "]
[{"$nulls":4},"Amifostine L155","Floxuridine "]
[{"$nulls":4},"Apraclonidine L264","Glucarpidase "]
[{"$nulls":4},"Bumetanide D; L158","Leucovorin "]
[{"$nulls":4},"Calcipotriol L148, L149, L150, L151, L152","Liraglutide "]
[{"$nulls":4},"Celecoxib DB43","Lumiracoxib"]
[{"$nulls":4},"Clevidipine L265, L266","Methsuximide "]
[{"$nulls":4},"Chenodeoxycholic acid L221","Nilutamide "]
[{"$nulls":4},"Cholecalciferol L148, L149, L150, L151, L152","Palifermin "]
[{"$nulls":4},"Colesevelam L159, L160","Pemetrexed"]
[{"$nulls":4},"Cyclandelate L128","Sulfadiazine "]
[{"$nulls":4},"Deferasirox L267"]
[{"$nulls":4},"Eltrombopag L268"]
[{"$nulls":4},"Erocalciferol L148, L149, L150, L151, L152"]
[{"$nulls":4},"Guanfacine L269"]
[{"$nulls":4},"Icatibant L122, L133"]
[{"$nulls":4},"Insulin regular L162"]
[{"$nulls":4},"Ketamine L270, L271"]
[{"$nulls":4},"Levobunolol L272"]
[{"$nulls":4},"Mannitol L273, L274, L275, L276"]
[{"$nulls":4},"Memantine L163"]
[{"$nulls":4},"Metipranolol L272"]
[{"$nulls":4},"Montelukast L277"]
[{"$nulls":4},"Nebivolol L278"]
[{"$nulls":4},"Nepafenac L164"]
[{"$nulls":4},"Nesiritide D"]
[{"$nulls":4},"Nitroprusside L138, L139, L140"]
[{"$nulls":4},"Norelgestromin L165, L166"]
[{"$nulls":4},"Paricalcitol L167"]
[{"$nulls":4},"Penicillamine L279"]
[{"$nulls":4},"Propofol L143, L144"]
[{"$nulls":4},"Selenium sulfide L170"]
[{"$nulls":4},"Sitaxentan L280"]
[{"$nulls":4},"Sulfisoxazole L281, L282"]
[{"$nulls":4},"Tizanidine L283"]
[{"$nulls":4},"Tolbutamide L284, L285"]
[{"$nulls":4},"Trimethoprim L286"]
[{"$nulls":4},"Urea L287, L288"]
[{"$nulls":4},"Zafirlukast L289, L290"]
[{"$nulls":3},"[%]",{"v":26.451612903225808,"d":"26.45"},{"v":8.38709677419355,"d":"8.39"}]
["Purple","P",31,"Bi- and trivalent cations, chelating agents","Mycophenolate mofetil D43; D; L307, L308","–"]
[{"$nulls":3},"[%]",{"v":3.225806451612903,"d":"3.23"},{"v":0,"d":"0.00"}]
[null,"TOTAL",1141,"[%]",{"v":21.647677475898337,"d":"21.65"},{"v":8.76424189307625,"d":"8.76"}]

{"sheet":"Cross-checking references","index":2,"n_rows":309,"n_cols":2,"rows_kept":309,"flags":["formulas_cached_only"]}
["L1","ZH Li, H Sato, Y Fukuda, M Kurokawa, S Kageyama, T Kawana, K Shiraki. Acyclovir treatment of skin lesions results in immune deviation in mice infected cutaneously with herpes simplex virus. Antiviral Chemistry and Chemotherapy (1999) 10(5):251-257"]
["L2","J Yao, Y Zhang, S Ramishetti, Y Wang, L Huang. Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate. J Control Release (2013) 170(3):414-420"]
["L3","RL Piao, YY Liu, D Tian, ZH Ma, M Zhang, CZhao, JQ Niu. Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B. Mol Med Rep (2012) 5(1):184-189"]
["L4","Y Jiang, W Li, L Yu, J Liu, G Xin, H Yan, P Sun, H Zhang, D Xu, J Niu. Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cell Mol Immunol (2011) 8(1):75-82"]
["L5","V Kumar. Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?  Purinergic Signal (2013) 9(2):145-165"]
["L6","L Antonioli, C Blandizzi, P Pacher, G Haskó. Immunity, inflammation and cancer: a leading role for adenosine. Nature Reviews Cancer (2013) 13:842-857 "]
["L7","L Hirsh, A Dantes, BS Suh, Y Yoshida, K Hosokawa, K Tajima, F Kotsuji, O Merimsky, A Amsterdam. Phosphodiesterase inhibitors as anti-cancer drugs. Biochem Pharmacol (2004) 68(6):981-988"]
["L8","DM Essayan. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol (1999) 57(9):965-973"]
["L9","BP Ramakers, NP Riksen, TH Stal, S Heemskerk, P van den Broek, WHM Peters, JG van der Hoeven, P Smits, P Pickkers.  Dipyridamole augments the antiinflammatory response during human endotoxemia. Critical Care (2011) 15(6):R289"]
["L10","P Habibollahi, N Mahboobi, S Esmaeili, S Safari, A Dabbagh, SM Alavian. Halothane-induced hepatitis: A forgotten issue in developing countries. Hepat Mon (2011) 11(1):3–6"]
["L11","PM Dansette,  E Bonierbale,  C Minoletti,  PH Beaune,  D Pessayre,  D Mansuy. Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet (1998) 23(4):443-451"]
["L12","SP Lee, SH Kim, TH Kim, JW Sohn, DH Shin, SS Park, HJ Yoon.  A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia. J Korean Med Sci (2010) 25(1):148-151"]
["L13","K Sasaki,  T Yamamoto,  M Kishi,  H Yokozeki,  K Nishioka. Acute exanthematous pustular drug eruption induced by mexiletine. Eur J Dermatol (2001) 11(5):469-471"]
["L14","JJ Field, G Lin, MM Okam, E Majerus, J Keefer, O Onyekwere, A Ross, F Campigotto, D Neuberg, J Linden, DG Nathan. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood (2013) 121(17):3329-3334"]
["L15","GQ Wang, YP Ding, YH Dong. Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients. J Viral Hepat   (2013) 20 Suppl 1:9-17"]
["L16","Y Chen, X Li, B Ye, X Yang, W Wu, B Chen, X Pan, H Cao, L Li. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res  (2011) 91(1):23-31"]
["L17","L Ma, YJ Cai, L Yu, JY Feng, J Wang, C Li, JQ Niu, YF Jiang. Treatment with Telbivudine Positively Regulates Antiviral Immune Proﬁles in Chinese Patients with Chronic Hepatitis B. Antimicrob. Agents Chemother (2013) 57(3):1304-1311"]
["L18","V Covelli, I Munno, P Decandia, M Altamura, B Cannuscio, AB Maffione, E Jirillo. Effects of benzodiazepines on the immune system. Acta Neurol (Napoli) (1991) 13(5):418-423"]
["L19","F Lechin, B van der Dijs, G Vitelli-Flores, S Báez, ME Lechin, AE Lechin, B Orozco, I Rada, G León, V Jiménez. Peripheral blood immunological parameters in long-term benzodiazepine users. Clin Neuropharmacol  (1994) 17(1): 63-72"]
["L20","A Condino-Neto, MM Vilela, EC Cambiucci, JD Ribeiro, AA Guglielmi, LA Magna, G De Nucci. Theophylline therapy inhibits neutrophil and mononuclear cell chemotaxis from chronic asthmatic children. Br J Clin Pharmacol (1991) 32(5):557-561"]
["L21","HG Moon, YS Kim, JP Choi, DS Choi, CM Yoon, SG Jeon, YS Gho, YK Kim. Aspirin attenuates the anti-inflammatory effects of theophylline via inhibition of cAMP production in mice with non-eosinophilic asthma. Experimental & Molecular Medicine (2010) 42:47-60"]
["L22","AM Kogelnik, K Loomis, M Hoegh-Petersen, F Rosso, C Hischier, JG Montoya. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein−Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Journal of Clinical Virology (2006) 37 Suppl. 1:S33-S38"]
["L23","JG Montoya, AM Kogelnik, M Bhangoo, MR Lunn, L Flamand, LE Merrihew, T Watt, JT Kubo, J Paik, M Desai. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol (2013) 85(12):2101-2109"]
["L24","A Di Gennaro, JZ Haeggström. The leukotrienes: immune-modulating lipid mediators of disease. Adv Immunol (2012) 116:51-92"]
["L25"," GJ Yuen,  S Weller,  GE Pakes. A review of the pharmacokinetics of abacavir. Clin Pharmacokinet  (2008) 47(6):351-371"]
["L26","W El-Sankary, V Bombail, GG Gibson, N Plant. Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos (2002) 30(9):1029-1034"]
["L27","YY Zhang, L Yang. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications. Expert Opin Drug Metab Toxicol (2009) 5(6):621-629"]
["L28","D Anglicheau, M Flamant, MH Schlageter, F Martinez, B Cassinat, P Beaune, C Legendre, E Thervet. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant (2003) 18(11):2409-2414"]
["L29","SK Lee, JJ Lee, HJ Lee, J Lee, BH Jeon, CD Jun, SK Lee, EC Kim. Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes. J Oral Pathol Med (2006) 35(4):218-226"]
["L30","A Sonesson, BB Rasmussen. In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450. Basic Clin Pharmacol Toxicol  (2011) 109(3):195-202"]
["L31","A Sonesson, BB Rasmussen. In vitro and in vivo human metabolism of degarelix, a gonadotropin-releasing hormone receptor blocker. Drug Metab Dispos (2013) 41(7):1339-1346"]
["L32","DG Hu, A Rogers, PI Mackenzie. Epirubicin upregulates UDP glucuronosyltransferase 2B7 expression in liver cancer cells via the p53 pathway. Mol Pharmacol (2014) 85(6):887-897"]
["L33","A Ozkan, K Fiskin. Epirubicin HCl Toxicity In Human Liver-Derived Hepatoma G2 Cells. Pol J Pharmacol (2004) 56:435–444"]
["L34","G Reimann, B Barthel, JK Rockstroh, D Spatz, NH Brockmeyer. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system. Int J Clin Pharmacol Ther (1999) 37(11):562-566"]
["L35","SA Sheweita. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice. Toxicology (2003) 191(2-3):133-142"]
["L36","JM Mathews, AS Etheridge, SR Black. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos (2002) 30(11):1153-1157"]
["L37","BJ Gurley, SF Gardner, MA Hubbard, DK Williams, WB Gentry, IA Khan, A Shah. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther (2005) 77(5):415-426"]
["L38","Y Wang, JP Gray, V Mishin, DE Heck, DL Laskin, JD Laskin. Distinct Roles of Cytochrome P450 Reductase in Mitomycin c Redox Cycling and Cytotoxicity. Mol Cancer Ther (2010) 9:1852-1863"]
["L39","HFJ Bligh, A Bartoszek, CN Robson, et al. Activation of Mitomycin C by NADPH:Cytochrome P-450 Reductase. Cancer Res (1990) 50:7789-7792"]
["L40","F Bressolle, S Khier, A Rochette, JM Kinowski, C Dadure, X Capdevila. Population pharmacokinetics of nalbuphine after surgery in children. Br J Anaesth (2011) 106(4):558-565"]
["L41","RA Stringer, C Strain-Damerell, P Nicklin, JB Houston. Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions. DMD (2009) 37(5):1025-1034"]
["L42","LC Wienkers, C Allievi, MJ Hauer, MA Wynalda. Cytochrome P-450-Mediated Metabolism Of The Individual Enantiomers Of The Antidepressant Agent Reboxetine In Human Liver Microsomes. DMD  (1999) 27(11):1334-1340"]
["L43","JK Coller, LL Christrup, AA Somogyi. Role of active metabolites in the use of opioids. Eur J Clin Pharmacol  (2009) 65:121-139"]
["L44","JY Kim, SM Lee. Vitamins C and E protect hepatic cytochrome P450 dysfunction induced by polymicrobial sepsis. Eur J Pharmacol (2006) 534(1-3):202-209"]
["L45","H Jiang, FE Harrison, K Jain, S Benjamin, JM May, JP Graves, DC Zeldin, JR Falck, BD Hammock, JC McGiff. Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids. Advances in Bioscience and Biotechnology (2012) 3:204-218"]
["L46","RP van Heeswijk, CL Cooper, BC Foster, BM Chauhan, F Shirazi, I Seguin, EJ Phillips, E Mills. Effect of high-dose vitamin C on hepatic cytochrome P450 3A4 activity. Pharmacotherapy (2005) 25(12):1725-1728"]
["L47","MW Clarke, JR Burnett, JH Wu, JM Hodgson, T Ledowski, IB Puddey, KD Croft. Vitamin E supplementation and hepatic drug metabolism in humans. J Cardiovasc Pharmacol (2009) 54(6):491-496"]
["L48","MW Clarke, Burnett JR, Croft KD. Vitamin E in human health and disease. Crit Rev Clin Lab Sci (2008) 45(5):417-50."]
["L49","C Abe, T Uchida, M Ohta, T Ichikawa, K Yamashita, S Ikeda. Cytochrome P450-dependent metabolism of vitamin E isoforms is a critical determinant of their tissue concentrations in rats. Lipids (2007) 42(7):637-645"]
["L50","WY Au, S Tam, BM Fong, YL Kwong. Determinants of cerebrospinal ﬂuid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood (2008) 112:3587-3590"]
["L51","P Zappasodi, M Rossi, I Ambaglio, P Bernasconi, A Corso, M Lazzarino, C Castagnola. Clinical efficacy of arsenic trioxide in a patient with acute promyelocytic leukemia with recurrent central nervous system involvement. Annals of Hematology (2011) 90(5):595-597"]
["L52","K Hao, Q Qi, H Hao, G Wang, Y Chen, et al. The Pharmacokinetic-Pharmacodynamic Model of Azithromycin for Lipopolysaccharide-Induced Depressive-Like Behavior in Mice. PLoS ONE (2013) 8(1):e54981"]
["L53","N Noe, L Dillon, V Lellek, F Diaz, A Hida, CT Moraes, T Wenz. Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy. Mitochondrion (2013) 13(5):417-426"]
["L54","M Dumont, C Stack, C Elipenahli, S Jainuddin, M Gerges, N Starkova, NY Calingasan, L Yang, D Tampellini, AA Starkov, RB Chan, G Di Paolo, A Pujol, M Flint Beal. Bezaﬁbrate administration improves behavioral deﬁcits and tau pathology in P301S mice. Hum Mol Genet (2012) 21(23):5091-5105"]
["L55","SS Agarwala, JM Kirkwood. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist (2000) 5(2):144-151"]
["L56","MJ Paul, Y Summers, AH Calvert, G Rustin, MH Brampton, N Thatcher, MR Middleton. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res (2002) 12(2):175-178"]
["L57","CM Celano, O Freudenreich, C Fernandez-Robles, TA Stern, MA Caro, JC Huffman. Depressogenic effects of medications: a review. Dialogues Clin Neurosci (2011) 13(1):109-125"]
["L58","D Müller, H Florkowski, K Chavez-Kattau, G Carlson, P Eggert. The effect of desmopressin on short-term memory in children with primary nocturnal enuresis. J Urology (2001) 166:2432-2434"]
["L59","JL Demolis, C Funck-Brentano, J Ropers, M Ghadanfar, DJ Nichols, P Jaillon. Influence of Dofetilide on QT-Interval Duration and Dispersion at Various Heart Rates During Exercise in Humans. Circulation (1996) 94:1592-1599"]
["L60","A Farkas, AS Farkas, D Vincze, P Makra, N Csík, I Leprán, A Varró, L Rudas. Examination of the role of the sympathetic nervous system in the proarrhythmic activity of dofetilide. J Mol Cell Cardiol (2007) 42(6):S7."]
["L61","RW Peters, LB Mitchell, MM Brooks, DS Echt, AH Barker, R Capone, PR Liebson, HL Greene. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). J Am Coll Cardiol (1994) 23(2):283-289"]
["L62","PJ Schwartz, SG Priori, E Vanoli, A Zaza. Influence of the Autonomic Nervous System on the Action of Antiarrhythmic Drugs. Antiarrhythmic Drugs. G Breithardt, M Borggrefe,  AJ Camm, M Shenasa, W Haverkamp,  G Hindricks (Editors) 1995 (Chapter 13), pp.240-250"]
["L63","Y Nagata. Flecainide augments muscle sympathetic nerve activity in humans. Circ J (2002) 66(4):377-381"]
["L64","LF López-Cortés, R Ruiz-Valderas, MJ Lucero-Muñoz, E Cordero, MT Pastor-Ramos, J Marquez. Intravitreal, Retinal, and Central Nervous System Foscarnet Concentrations after Rapid Intravenous Administration to Rabbits. Antimicrob Agents Chemother (2000) 44(3):756–759"]
["L65","P Cinque, GM Cleator, T Weber, P Monteyne, C Sindic, G Gerna, AM van Loon, PE Klapper. Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. J NeuroVirol (1998) 4:120-132"]
["L66","CR Tapping, AT Thackeray, RJV Bartlett, C Rowlande-Hill, P Maliakal. Evaluation of spinal dural arteriovenous ﬁstulae with gadofosveset trisodium at 3T (TRICKS and LAVA). Clin Radiol (2011) 66(9):865-868"]
["L67","N Moorthy, N Raghavendra, PN Venkatarathnamma. Levofloxacin-induced acute psychosis. Indian J Psychiatry (2008) 50(1):57–58"]
["L68","CM Celano, O Freudenreich, C Fernandez-Robles, TA Stern, MA Caro, JC Huffman. Depressogenic effects of medications: a review. Dialogues Clin Neurosci (2011) 13(1): 109–125"]
["L69","MF Grill, RK Maganti. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol (2011) 72(3):381–393"]
["L70","BA Lipsky, CA Baker. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis (1999) 28(2):352-364"]
["L71","DB Campbell, F Brackman. Cardiovascular protective properties of indapamide. Am J Cardiol (1990) 65(17):11H-27H"]
["L72","JM Chillon, GL Baumbach. Effects of Indapamide, a Thiazide-Like Diuretic, on Structure of Cerebral Arterioles in Hypertensive Rats. Hypertension (2004) 43:1092-1097"]
["L73","R Gaggi, R Dall'Olio, P Roncada, AM Gianni. Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system. Gen Pharmacol (1995) 26(2):303-308"]
["L74","R Gaggi, R Dall'olio, P Roncada, AM Gianni. Effects of isradipine and darodipine on serotonergic system of the rat brain. Pharmacol Biochem Be (1995) 51(2-3):183-187"]
["L75","J Rolski, B Karczmarek-Borowska, A Smietana. The possibility of lapatinib treatment for breast cancer patients with central nervous system metastases. Case study and literature review. Contemp Oncol (Pozn) (2012) 16(6):582-585"]
["L76","S Sutherland, S Johnston. Central Nervous System Tumours in Women Who Received Capecitabine and Lapatinib Therapy for Metastatic Breast Cancer. Tumors of the Central Nervous System (2011) 3:97-106"]
["L77","S Sandmann, JY Min, A Meissner, T Unger. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca2+-handling in infarct-induced heart failure in rats. Cardiovasc Res (1999) 44 (1):67-80"]
["L78","Y Lu, M Long, S Zhou, Z Xu, F Hu, M Li. Mibefradil reduces blood glucose concentration in db/db mice. Clinics (2014) 69(1):61-67"]
["L79","GJ Molderings, J Likungu, M Göthert. N-Type Calcium Channels Control Sympathetic Neurotransmission in Human Heart Atrium. Circulation (2000) 101:403-407 "]
["L80","RC. Owens Jr., PG Ambrose. Antimicrobial Safety: Focus on Fluoroquinolones. Clin Infect Dis (2005) 41(Suppl 2):S144-S157"]
["L81","H Zhou, J Gao, D Zou, W Wu, Z Li. Effect of octreotide on enteric motor neurons in experimental acute necrotizing pancreatitis. PLoS One (2012) 7(12):e52163"]
["L82","R Sciuto, A Ferraironi, A Semprebene, E Occhipinti, R Mastrostefano, M Crecco, M Mottolese, CL Maini. Clinical relevance of 111In-octreotide scans in CNS tumors. Q J Nucl Med (1995) 39(4 Suppl 1):101-103"]
["L83","D Alexandru, MJ Glantz, L Kim, MC Chamberlain, DA Bota. Pulmonary Metastases in Patients With Recurrent, Treatment-Resistant Meningioma. Prognosis and Identification by 111Indium-Octreotide Imaging. Cancer (2011) 117(19):4506-4511"]
["L84","EA Lawson, LM Holsen, M Santin, R DeSanti, E Meenaghan, KT Eddy, DB Herzog, JM Goldstein, A Klibanski. Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. J Clin Psychiatry (2013) 74(5):e451-457"]
["L85","L Garfield, C Giurgescu, CS Carter, D Holditch-Davis, BL McFarlin, D Schwertz, JS Seng, R White-Traut. Depressive symptoms in the second trimester relate to low oxytocin levels in African-American women: a pilot study. Arch Womens Ment Health (2014) Jun 21 [Epub ahead of print]"]
["L86","M Skrundz, M Bolten, I Nast, DH Hellhammer, G Meinlschmidt. Plasma Oxytocin Concentration during Pregnancy is associated with Development of Postpartum Depression. Neuropsychopharmacol (2011) 36:1886-1893"]
["L87","F Yang. Amylin in vasodilation, energy expenditure and inflammation. Front Biosci (Landmark Ed) (2014) 19:936-944"]
["L88","IG Schmidt, LH Schmidt. Neurotoxicity Of The 8-Aminoquinolines: III. The Effects Of Pentaquine, Isopentaquine, Primaquine, And Pamaquine On The Central Nervous System Of The Rhesus Monkey. J Neuropathol Exp Neur (1951) 10(3):231-256"]
["L89","D Colle, DB Santos, ELG Moreira, JM Hartwig, AA dos Santos, LT Zimmermann, MA Hort, M Farina. Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats. PLoS ONE (2013) 8(6): e67658"]
["L90","J de Gans, P Portegies, P Reiss, D Troost, T van Gool, JM Lange. Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS. J Acquir Immune Defic Syndr (1992) 5(2):137-142"]
["L91","C Leport, F Raffi, S Matheron, C Katlama, B Regnier, AG Saimot, C Marche, C Vedrenne, JL Vilde. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am J Med (1988) 84(1):94-100"]
["L92","M Chegounchi, MG Hanna, GH Neild. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation. BMC Nephrol (2006) 7:7"]
["L93","G Vizzini, M Asaro, R Miraglia, S Gruttadauria, D Fili, A D’Antoni, I Petridis, G Marrone, D Pagano, B Gridelli. Changing Picture of Central Nervous System Complications in Liver Transplant Recipients. Liver Transplant (2011) 17:1279-1285 "]
["L94","IH Klein, AC Abrahams, T van Ede, PL Oey, G Ligtenberg, PJ Blankestijn. Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity. J Hypertens (2010) 28(9):1928-1934"]
["L95","I Számel, I Hindy, B Budai, L Kangas, A Hajba, R Lammintausta. Endocrine mechanism of action of toremifene at the level of the central nervous system in advanced breast cancer patients. Cancer Chemother Pharmacol (1998) 42(3):241-246"]
["L96","Y Matsuda, Y Masuda, B Blattberg, MN Levy. The effects of cocaine, chlorpheniramine and tripelennamine on the cardiac responses to sympathetic nerve stimulation. Eur J Pharmacol (1980) 63(1):25-33"]
["L97","R Oishi, S Shishido, M Yamori, K Saeki. Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol (1994) 349(2):140-144"]
["L98","Z Ge, Y Da, Z Xue, K Zhang, H Zhuang, M Peng, Y Li, W Li, A Simard, J Hao, Z Yao, R Zhang. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis. Exp Neurol (2013) 241:56-66"]
["L99","VSR Atluri, S Pilakka-Kanthikeel, T Samikkannu,V Sagar, KRV Kurapati, SK Saxena, A Yndart, A Raymond, H Ding, O Hernandez, MPN Nair. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol Brain (2014) 7:37"]
["L100","BB Friday, SK Anderson, J Buckner, C Yu, C Giannini, F Geoffroy, J Schwerkoske, M Mazurczak, H Gross, E Pajon, K Jaeckle, E Galanis. Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study. Neuro Oncol (2012) 14(2):215-221"]
["L101","C Shibao, A Gamboa, A Diedrich, C Dossett, L Choi, G Farley, I Biaggioni . Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension (2007) 50(1):54-61"]
["L102","T Fukushima, M Asahina, Y Fujinuma, Y Yamanaka, A Katagiri, M Mori, S Kuwabara. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. J Neurol (2013) 260(2):475-483"]
["L103","LM Nicol, NL Mills, IR Starkey. Amyl nitrite induced cerebral and coronary vasospasm. Q J Med (2011) 104:83-84"]
["L104","E Klemenska, A Beresewicz. Bioactivation of organic nitrates and the mechanism of nitrate tolerance. Cardiol J (2009) 16(1):11-19"]
["L105","BG Phillips, M Kato, CA Pesek, M Winnicki, K Narkiewicz, D Davison, VK Somers. Sympathetic activation by sildenafil. Circulation (2000) 102(25):3068-3073"]
["L106","A Al-Hesayen, JS Floras, JD Parker. The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure. European Journal of Heart Failure (2006) 8:864-868"]
["L107","RTCE Robinson, ND Harris, RH Ireland, A Lindholm, SR Heller. Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization Br J Clin Pharmacol (2003) 55(3):246-251"]
["L108","P Skovsted, S Sapthavichaikul. The effects of isoflurane on arterial pressure, pulse rate, autonomic nervous activity, and barostatic reflexes. Canadian Anaesthetists’ Society Journal (1977) 24(3):304-314"]
["L109","BD Miller, MD Thames, AL Mark. Inhibition of cardiac sympathetic nerve activity during intravenous administration of lidocaine. J Clin Invest (1983)71(5):1247–1253"]
["L110","KA Ellenbogen, ML Smith, LA Beightol, DL Eckberg. Influence of lidocaine on human muscle sympathetic nerve activity during programmed electrical stimulation and ventricular tachycardia. Am Heart J (1992) 124(4):891-897"]
["L111","G Boccara, J Eliet, Y Pouzeratte, C Mann, P Colson. Pre-emptive lidocaine inhibits arterial vasoconstriction but not vasopressin release induced by a carbon dioxide pneumoperitoneum in pigs. British Journal of Anaesthesia (2003) 90(3):343-348 "]
["L112","D Manzella, R Grella, K Esposito, D Giugliano, M Barbagallo, G Paolisso. Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration. Am J Hypertens (2004)  17(3):223-227"]
["L113","S Sugimoto, H Nakajima, K Kodo, J Mori, K Matsuo, K Kosaka, W Aoi, K Yoshimoto, H Ikegaya, H Hosoi. Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice. Nutr Metab (Lond) (2014) 11(1):14"]
["L114","EK Jackson, Z Mi. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension (2008) 51(6):1637-1642"]
["L115","S Pastromas. Diabetes Mellitus: Dipeptidyl Peptidase 4 Inhibitors and Cardiovascular Outcomes, Hospital Chronicles (2014) 9(2):1-5"]
["L116","RK Dix, GJ Kelliher, N Jurkiewicz, JB Smith. Effect of Sulfinpyrazone on Ventricular Arrhythmia, Prostaglandin Synthesis, and Catecholamine Release Following Coronary Artery Occlusion in the Cat. Journal of Cardiovascular Pharmacology (1982) 4(6):1068-1076"]
["L117","EA Raeder, RL Verrier, B Lown. Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart. Am J Cardiol (1982) 50:271-275"]
["L118","M Hirohashi, K Takasuna, Y Kasai, C Usui, H Kojima. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems. Arzneimittelforschung. (1991) 41(1):19-24"]
["L119","KC Lee, DC Randall. Potentiation of the pressor response to stress by tolbutamide in dogs. Integrative Physiological and Behavioral Science (1993) 28(1):22-28"]
["L120","G Bauriedel, D Skowasch, M Schneider, R Andrié, A Jabs, B Lüderitz. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. Am Heart J (2003) 145(2):343-348"]
["L121","MH Strauss, AS Hall. Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction. Circulation (2006) 114:838-854 "]
["L122","D Skowasch, A Viktor, M Schneider-Schmitt, B Lüderitz,G Nickenig, G Bauriedel. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril. Clinical Research in Cardiology (2006) 95(4):212-216"]
["L123","L Kalinowski, T Matys, E Chabielska, W Buczko, T Malinski. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension (2002) 40(4):521-527"]
["L124","M Schwemmer, O Sommer, E Bassenge. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling. Cardiovasc Drugs Ther (2001) 15(4):301-307"]
["L125","R Woodman, C Brown, W Lockette. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension (2010) 56(3):463-470"]
["L126","MP Ortega, MC García, MA Gijón, MF de Casa-Juana, JG Priego, M Sanchez Crespo, C Sunkel. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. J Pharmacol Exp Ther (1990) 255(1):28-33"]
["L127","P Hjemdahl, NH Wallen. Calcium antagonist treatment, sympathetic activity and platelet function. European Heart Journal (1997) 18 (Suppl A):A36-A50"]
["L128","WE van den Hoven, DW Hall. Inhibition of human platelet functions by cyclandelate. Drugs (1987) 33 (Suppl 2):41-52"]
["L129","JA Ware, JB Schwartz, JK Horak, RT Solis. Inhibition of platelet aggregation by oral digoxin and reversal with nifedipine. J Cardiovasc Pharmacol (1985) 7(2):262-266"]
["L130","JA Chirinos, A Castrellon, JP Zambrano, JJ Jimenez, W Jy, LL Horstman, HJ Willens, A Castellanos, RJ Myerburg, YS Ahn. Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. Heart Rhythm (2005) 2(5):525-529"]
["L131","G Gleerup, JR Petersen, J Mehlsen, K Winther. Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension. Angiology (1996) 47(10):951-955"]
["L132","LJ Murphey, HA Malave, J Petro, I Biaggioni, DW Byrne, DE Vaughan, JM Luther, M Pretorius, NJ Brown. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. J Pharmacol Exp Ther (2006) 318(3):1287-1292"]
["L133","AM Marney, J Ma, JM Luther, T Alp Ikizler, NJ Brown. Endogenous Bradykinin Contributes to Increased Plasminogen Activator Inhibitor 1 Antigen following Hemodialysis. J Am Soc Nephrol (2009) 20:2246 –2252"]
["L134","M Falciani, B Rinaldi, B D'Agostino, F Mazzeo, S Rossi, B Nobili, F Rossi, A Filippelli. Effects of nebivolol on human platelet aggregation. J Cardiovasc Pharmacol (2001) 38(6):922-929"]
["L135","D Salvemini, G de Nucci, JM Sneddon, JR Vane. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol (1989) 97(4):1145-1150"]
["L136","D Praticò, M Pasin, OP Barry, A Ghiselli, G Sabatino, L Iuliano, GA FitzGerald, F Violi. Iron-Dependent Human Platelet Activation and Hydroxyl Radical Formation: Involvement of Protein Kinase C. Circulation (1999) 99:3118-3124 "]
["L137","J Liu, BB Gao, AC Clermont, P Blair, TJ Chilcote, S Sinha, R Flaumenhaft, EP Feener. Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nature Medicine (2011) 17:206-210 "]
["L138","AL Pasqui, PL Capecchi, L Ceccatelli, S Mazza, A Gistri, F Laghi Pasini, T Di Perri. Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin. Thromb Res (1991) 61(2):113-122"]
["L139","SN Harris, CS Rinder, HM Rinder, JB Tracey, BR Smith, R Hines. Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. Anesthesiology (1995) 83(6):1145-1152"]
["L140","HG Topf, M Rauh, W Rascher, J Dötsch, JM Klinge. Endothelial cells influence the sodium nitroprusside mediated inhibition of platelet aggregation by an as yet unkown pathway. Thrombosis Journal (2012) 10:6"]
["L141","JE Macdonald, AD Struthers. What Is the Optimal Serum Potassium Level in Cardiovascular Patients? Journal of the American College of Cardiology (2004) 43(2):155-161"]
["L142","M Kimura, X Lu, J Skurnick, G Awad, J Bogden, F Kemp, A Aviv. Potassium Chloride Supplementation Diminishes Platelet Reactivity in Humans. Hypertension (2004) 44:969-973"]
["L143","JP De La Cruz, MV Páez, JA Carmona, FS De La Cuesta. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. Br J Pharmacol (1999) 128(7):1538-1544"]
["L144","NL Law, KFJ Ng, MG Irwin, JSF Man. Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol. Br J Anaesth (2001) 86(1):94-98 "]
["L145","J Zeck, J Schallheim, SQ Lew, L DePalma. Whole Blood Platelet Aggregation and Release Reaction Testing in Uremic Patients. BioMed Research International. Vol. 2013, Article ID 486290, 6 pages, doi:10.1155/2013/486290"]
["L146","GE Linthorst, HJ Avis, M Levi. Uremic thrombocytopathy is not about urea. J Am Soc Nephrol (2010) 21(5):753–755"]
["L147","TP O'Barr, EW Swanson, JE Fitzpatrick, DG Corby. Effect of minoxidil on platelet function and the synthesis of prostaglandins in platelets. J Lab Clin Med (1989) 114(5):575-578"]
["L148","G Verhave, CEH Siegert. Role of vitamin D in cardiovascular disease. The Netherlands Journal of Medicine (2010) 68(3):113-118"]
["L149","KES Poole, N Loveridge, PJ Barker, DJ Halsall, C Rose, J Reeve, EA Warburton. Reduced Vitamin D in Acute Stroke. Stroke (2006) 37:243-245"]
["L150","YC Ku, ME Liu, CS Ku, TY Liu, SL Lin. Relationship between vitamin D deficiency and cardiovascular disease.World J Cardiol (2013) 5(9):337–346"]
["L151","Y Zheng, J Zhu, M Zhou, L Cui, W Yao, et al. Meta-Analysis of Long-Term Vitamin D Supplementation on Overall Mortality. PLoS ONE (2013) 8(12):e82109"]
["L152","JA Sugden, JI Davies, MD Witham, AD Morris, AD Struthers. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine (2008) 25(3):320-325"]
["L153","TJ Neiva, DM Fries, HP Monteiro, EA D'Amico, DA Chamone. Aluminum induces lipid peroxidation and aggregation of human blood platelets. Braz J Med Biol Res (1997) 30(5):599-604"]
["L154","TJ Neiva, AL Benedetti, SM Tanaka, JI Santos, EA D'Amico. Determination of serum aluminum, platelet aggregation and lipid peroxidation in hemodialyzed patients. Braz J Med Biol Res (2002) 35(3):345-350"]
["L155","C Porta, A Maiolo, A Tua, G Grignani. Amifostine, a reactive oxygen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Haematologica (2000) 85:820-825 "]
["L156","TA Khan, C Bianchi, P Voisine, J Sandmeyer, J Feng, FW Sellke. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis. Ann Thorac Surg (2005) 79(5):1545-1550"]
["L157","O Shigeta, H Kojima, T Jikuya, Y Terada, N Atsumi, Y Sakakibara, T Nagasawa, T Mitsui. Aprotinin Inhibits Plasmin-Induced Platelet Activation During Cardiopulmonary Bypass. Circulation (1997) 96: 569-574"]
["L158","A Spalding, H Vaitkevicius, S Dill, S MacKenzie, A Schmaier, W Lockette. Mechanism of Epinephrine-Induced Platelet Aggregation. Hypertension (1998) 31:603-607"]
["L159","S Ueda, M Katagiri, Y Matsumoto, T Nishimura, S Matsushita, M Mori, T Ozawa, H Orimo. Nitric oxide-dependent inhibition of platelet aggregation in elderly patients with hypercholesterolemia. Nihon Ronen Igakkai Zasshi (2001) 38(2):177-184"]
["L160","R Pathansali, N Smith, P Bath. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets (2001) 12(5):292-297"]
["L161","KC Srivastava, KK Awasthi. Effect of furosemide on the in vitro prostaglandin biosynthesis in human platelets. Prostaglandins Leukot Med (1982)  9(2):211-221"]
["L162","M Trovati, G Anfossi, F Cavalot, P Massucco, E Mularoni, G Emanuelli. Insulin Directly Reduces Platelet Sensitivity To Aggregating Agents. Diabetes (1988) 37(6):780-6786"]
["L163","ML Kalev-Zylinska, TN Green, MC Morel-Kopp, PP Sun, YE Park, A Lasham, MJ During, CM Ward. N-methyl-d-aspartate receptors amplify activation and aggregation of human platelets. Thromb Res (2014) 133(5):837-847"]
["L164","BI Gaynes, A Onyekwuluje. Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension. Clin Ophthalmol (2008) 2(2): 355-368"]
["L165","M Zerr-Fouineau, M Chataigneau, C Blot, VB Schini-Kerth. Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors. FASEB J (2007) 21(1):265-273"]
["L166","M Zerr-Fouineau, M Jourdain, C Boesch, M Hecker, C Bronner, VB Schini-Kerth. Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells. Arterioscler Thromb Vasc Biol (2009) 29(4):586-593"]
["L167","SN Verouti, AB Tsoupras, F Alevizopoulou, CA Demopoulos, C Iatrou. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. Int J Artif Organs (2013) 36(2):87-96"]
["L168","NM Tun, GM Villani. Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis. J Thromb Thrombolysis (2012) 34(3):347-359"]
["L169","K Darabi, AH. Berg. Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP. Am J Clin Pathol (2006) 125:592-597"]
["L170","K Yoshizawa, A Ascherio, JS Morris, MJ Stampfer, E Giovannucci, CK Baskett, WC Willett, EB Rimm. Prospective Study of Selenium Levels in Toenails and Risk of Coronary Heart Disease in Men. Am J Epidemiol (2003) 158:852–860"]
["L171","AG Paradelis, C Triantaphyllidis, MM Giala. Neuromuscular blocking activity of aminoglycoside antibiotics. Methods Find Exp Clin Pharmacol (1980) 2(1):45-51"]
["L172","M Liu, M Kato, Y Hashimoto. Neuromuscular Blocking Effects of the Aminoglycoside Antibiotics Arbekacin, Astromicin, Isepamicin and Netilmicin on the Diaphragm and Limb Muscles in the Rabbit. Pharmacology (2001) 63:142-146 "]
["L173","TR Pasquale, JS Tan. Nonantimicrobial Effects of Antibacterial Agents. Clinical Infectious Diseases (2005) 40:127-135"]
["L174","O al Ahdal, DR Bevan. Clindamycin-induced neuromuscular blockade. Can J Anaesth (1995) 42(7):614-617"]
["L175","JF Fiekers. Sites and mechanisms of antibiotic-induced neuromuscular block: a pharmacological analysis using quantal content, voltage clamped end-plate currents and single channel analysis. Acta Physiol Pharmacol Ther Latinoam (1999) 49(4):242-250"]
["L176","K Finstad, JR Guajardo, C Scoville. Neuralgic amyotrophy associated with antibiotic therapy. Ann Pharmacother (2008) 42(9):1344-1347"]
["L177","K Al Alawi,  M Al Shinawy, A Taqee,Y Wali. An Overlooked Complication of Vancomycin Induced Acute Flaccid Paralysis in a Child with Acute Leukemia: A Case Report. Oman Med J (2011) 26(4):283–284"]
["L178","EA Yetley. Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions1–3, Am J Clin Nutr (2007) 85 (suppl):269S–76S"]
["L179","M Buzatu, C Bulteau, C Altuzarra, O Dulac, P Van Bogaert. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia (2009) 50(Suppl 7):68–72"]
["L180","M Kurian, CM Korff. Steroids in Pediatric Epilepsy: Infantile Spasms and Beyond… Epileptologie (2011) 28:15 – 20"]
["L181","V Bomben, J Holth, J Reed, P Cramer, G Landreth, J Noebels. Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy. Neurobiol Aging (2014) 35(9):2091-2095"]
["L182","MF Gordon, RI Abrams, DB Rubin, WB Barr, DD Correa. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Movement Disorders (1995) 10(2):220–222 "]
["L183","A Thiry, JM Dogné, CT Supuran, B Masereel. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem (2007) 7(9):855-864"]
["L184","MA Pinard,MA Boonex, BD Rife, CT Supuran, R McKenna. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. Bioorg Med Chem (2013) 21(22):7210-7215"]
["L185","T Bäckström. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand (1976) 54(4):321-347"]
["L186","J Velíšková, G De Jesus, R Kaur, L Velíšek. Females, their estrogens and seizures. Epilepsia (2010) 51(Suppl 3):141-144"]
["L187","CL Harden, AG Herzog, BG Nikolov, BS Koppel, PJ Christos, K Fowler, DR Labar, WA Hauser. Hormone replacement therapy in women with epilepsy: A randomized, double-blind, placebo-controlled study. Epilepsia (2006) 47(9):1447-1451"]
["L188","A Verrotti, C D’Egidio, S Agostinelli, C Verrotti, P Pavone. Diagnosis and management of catamenial seizures: a review. International Journal of Women’s Health (2012) 4:535–541"]
["L189","N Steeghs, FE de Jongh, PA Sillevis Smitt, MJ van den Bent. Cisplatin-induced encephalopathy and seizures. Anticancer Drugs (2003) 14(6):443-446"]
["L190","CY Cheng, YC Lin, JS Chen,CH  Chen, ST Deng. Cisplatin-induced acute hyponatremia leading to a seizure and coma: a case report. Chang Gung Med J (2011) 34(6 Suppl):48-51"]
["L191","L Amit, I Ben-Aharon, T Tichler, E Inbar, A Sulkes, S Stemmer. Cisplatin-Induced Posterior Reversible Encephalopathy Syndrome—Brief Report and Review of the Literature. Journal of Behavioral and Brain Science (2012) 2(1): 97-101"]
["L192","M Najafi, MMSadeghi, J Mehvari, M Zare, M Akbari. Progesterone therapy in women with intractable catamenial epilepsy. Adv Biomed Res (2013) 2:8"]
[null,"S Baxendale, CJ Holdsworth, PLM Santoscoy, MRM Harrison, J Fox, CA Parkin, PW Ingham, VT Cunliffe. Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures. Dis Model Mech (2012) 5(6):773-784"]
["L194","EB Ing, SY Ing, T Ing, JA Ramocki. The complication rate of edrophonium testing for suspected myasthenia gravis. Can J Ophthalmol (2000) 35(3):141-144; discussion 145"]
["L195","P Waciński. Influence of felodipine on experimental seizures and activity of different antiepileptic drugs in mice. Pol J Pharmacol (1998) 50(1):23-29"]
["L196","EH Reynolds. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry (2002)72:567-571"]
["L197","S el Kalla, NS Menon. Mebendazole poisoning in infancy. Ann Trop Paediatr (1990) 10(3):313-314"]
["L198","D Zador,  S Mayet, J Strang. Commentary: Decline in methadone-related deaths probably relates to increased supervision of methadone. UK Int J Epidemiol (2006) 35 (6):1586-1587"]
["L199","VL  Smith-Swintosky, LC Pettigrew, RM Sapolsky, C Phares, SD Craddock, SM Brooke, MP Mattson. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab (1996) 16(4):585-598"]
["L200","JG Larkin, FM Besag, A Cox, J Williams, MJ Brodie. Nifedipine for epilepsy? A double-blind, placebo-controlled trial. Epilepsia (1992) 33(2):346-352"]
["L201","S Otoom, Z Hasan. Nifedipine inhibits picrotoxin-induced seizure activity: further evidence on the involvement of L-type calcium channel blockers in epilepsy. Fundam Clin Pharmacol (2006) 20(2):115-119"]
["L202","LA Chaney, RW Rockhold, RW Wineman, AS Hume. Anticonvulsant-resistant seizures following pyridostigmine bromide (PB) and N,N-diethyl-m-toluamide (DEET). Toxicol Sci (1999) 49(2):306-311"]
["L203","HE Scharfman, GH Malthankar-Phatak, D Friedman, P Pearce, DP McCloskey, CL Harden, NJ Maclusky. A rat model of epilepsy in women: a tool to study physiological interactions between endocrine systems and seizures. Endocrinology (2009) 150(9):4437-442"]
["L204","C Maritaz, F Lemare, A Cherif, S Demirdjian, DV Couanet, C Dufour. High-dose thiotepa: Neurotoxicity and risk factors in children with solid tumors. J Clin Oncol (2012) 30 (suppl; abstr 9572)"]
["L205","KA Grosset, DG Grosset. Prescribed drugs and neurological complications. J Neurol Neurosurg Psychiatry (2004) 75(supl III):iii2-iii8 "]
["L206","AJ Dutton, C Hepburn, DW Macdonald. A Stated Preference Investigation into the Chinese Demand for Farmed vs. Wild Bear Bile. PLoS ONE (2011) 6(7): e21243"]
["L207","Y Feng, K Siu, N Wang, KM Ng, SW Tsao, T Nagamatsu, Y Tong. Bear bile: dilemma of traditional medicinal use and animal protection. J Ethnobiol Ethnomed (2009) 5:2"]
["L208","LA Horrigan, JP Kelly, TJ Connor. Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther (2006) 111(3):877-892"]
["L209","E Ortega, MA de Pablo, AM Gallego, JJ Gaforio, C Alvarez, A Ruiz-Bravo, GA de Cienfuegos. Modification of acquired immunity in mice by imipenem/cilastatin. J Antimicrob Chemother (1999) 44(4):561-564"]
["L210","J Chang, E Blazek, M Skowronek, L Marinari, RP Carlson. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition. Eur J Pharmacol (1987) 142(2):197-205"]
["L211","AL Pasqui, M Di Renzo, F Bruni, G Fanetti, G Campoccia, A Auteri. Imipenem and immune response: in vitro and in vivo studies. Drugs Exp Clin Res (1995) 21(1):17-22"]
["L212","R Leone, M Venegoni, D Motola, U Moretti, V Piazzetta, A Cocci, D Resi, F Mozzo, G Velo, L Burzilleri, N Montanaro, A Conforti. Adverse Drug Reactions Related to the Use of Fluoroquinolone Antimicrobials. Drug Safety (2003) 26(2):109-120"]
["L213","M Chalumeau, S Tonnelier, P d’Athis, JM Tréluyer, D Gendrel, G Bréart, G Pons. Fluoroquinolone Safety in Pediatric Patients: A Prospective, Multicenter, Comparative Cohort Study in France. Pediatrics (2003) 111:e714-e719"]
["L214","A Mohammadzadeh, M Heidari, H Soltanghoraee, M Jeddi-Tehrani, M Ghaffari Novin, MM Akhondi,H  Zeraati, F Mohammadzadeh. Evaluation of the effect of pentoxifylline on white blood cell count in serum and peritoneal fluid in female rats with endometriosis. J Obstet Gynaecol Res (2008) 34(3):307-313"]
["L215","LT Fourman, B Robert Meyer. Autoimmune hepatitis in association with ramelteon. J Clin Gastroenterol (2013) 47(7):651-654"]
["L216","SR Pandi-Perumal, V Srinivasan, DW Spence, A Moscovitch, R Hardeland, GM Brown, DP Cardinali. Ramelteon: a Review of its Therapeutic Potential in Sleep Disorders. Adv Ther (2009) 26(6):613-626"]
["L217","W Diederichs, CG Stief, TF Lue, EA Tanagho. Sympathetic inhibition of papaverine induced erection. J Urol (1991) 146(1):195-198"]
["L218","CWF Clarke, EO El-Mahdi. Confusion and paranoia associated with oral tocainide. Postgraduate Medical Journal (1985) 61:79-81"]
["L219","IM Whyte, NA Buckley,DM  Reith, I Goodhew, M Seldon, Dawson AH. Acetaminophen causes an increased International Normalized Ratio by reducing functional factor VII. Ther Drug Monit (2000) 22(6):742-748"]
["L220","YL Peng, HY Hu, JC Luo, MC Hou, HC Lin, FY Lee. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study. Osteoporos Int (2014) 25(5):1617-1623"]
["L221","G Baele, R Beke, F Barbier. In vitro inhibition of platelet aggregation by bile salts. Thromb Haemost (1980) 44(2):62-64"]
["L222","K Vroonhof, HJ van Rijn, J van Hattum. Vitamin K deficiency and bleeding after long-term use of cholestyramine. Neth J Med (2003) 61(1):19-21"]
["L223","RS Birjmohun, G Kees Hovingh, ES Stroes, JJ Hofstra, GM Dallinga-Thie, JC Meijers, JJ Kastelein, M Levi. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema. Clin Ther (2008) 30(12):2314-2323"]
["L224","R Krysiak, W Zmuda, B Okopień. The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol (2012) 26(3):424-431"]
["L225","KC Tan, ED Janus, KS Lam. Effects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus. Am J Cardiol (1999) 84(8):934-937, A7"]
["L226","DE Ferrara, X Liu, RG Espinola, PL Meroni, I Abukhalaf, EN Harris, SS Pierangeli. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis Rheum (2003) 48(11):3272-3279"]
["L227","M Totan, A Dagdemir, AR Ak, D Albayrak, S Kucukoduk. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia. Med Pediatr Oncol (2001) 36(4):429-433"]
["L228","HR Haak, KM Caekebeke-Peerlinck, AP van Seters, E Briët. Prolonged bleeding time due to mitotane therapy. Eur J Cancer (1991) 27(5):638-641"]
["L229","M Elhakim, A Fathy, H Amine, A Saeed, M Mekawy. Effect of i.v. tenoxicam during caesarean delivery on platelet activity. Acta Anaesthesiologica Scandinavica (2000) 44(5):555–559 "]
["L230","H Pieringer, B Schmekal, G Biesenbach, E Pohanka. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline. Ann Hematol (2010) 89(10):1063-1064"]
["L231","Y Wada, H Hasegawa, M Nakamura, N Yamaguchi. Anticonvulsant effect of allopurinol on hippocampal-kindled seizures. Pharmacol Biochem Behav (1992) 42:899–901"]
["L232","PG Zagnoni, A Bianchi, P Zolo, R Canger, C Cornaggia, P D'Alessandro, et al. Allopurinol as add-on therapy in refractory epilepsy: a double-blind placebo-controlled randomized study. Epilepsia (1994) 35:107–112"]
["L233","SA Said. Anticonvulsant Effect Of Bosentan. Benha MJ (1998) 15(1):167-175 Available at http://www.psychiatry-research-eg.com/texts/ins/a3ahb3.pdf"]
["L234","SB Hwang, HY Lee, HY Kim, ES Lee, JW Bae. Life-Threatening Acute Hyponatremia with Generalized Seizure Induced by Low-Dose Cyclophosphamide in a Patient with Breast Cancer. J Breast Cancer (2011) 14(4):345–348"]
["L235","A Undas, M Celinska-Löwenhoff, T Löwenhoff, A Szczeklik. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost (2006) 4(5):1029-1036"]
["L236","K Weiss, RL Allgren, S Sellers. Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficileInfections. Clin Infect Dis (2012) 55 (suppl 2):S110-S115"]
["L237","F Mohagheghi, L Khalaj, A Ahmadiani, B Rahmani. Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion. Neurotox Res (2013) 23(3):225-237"]
["L238","AK Rehni, TG Singh. Levamisole-induced reduction in seizure threshold: a possible role of nicotinic acetylcholine receptor-mediated pathway. Naunyn Schmiedebergs Arch Pharmacol (2010) 382(3):279-285"]
["L239","BS Brozanski, MS Scher, AL Albright. Intraventricular nafcillin-induced seizures in a neonate. Pediatr Neurol (1988) 4(3):188-190"]
["L240","JE Zimmer, CR Spillert, S Puppala, K Zamecki, BA Bhatt, RR Arora. Pravastatin potentiates the anticoagulant effects of low molecular weight heparin. Thromb Res (2004) 113(6):407-410"]
["L241","P Sterzer, F Meintzschel, A Rösler, H Lanfermann, H Steinmetz, M Sitzer. Pravastatin Improves Cerebral Vasomotor Reactivity in Patients With Subcortical Small-Vessel Disease. Stroke (2001) 32:2817-2820 "]
["L242","L Serghides, CR McDonald, Z Lu, M Friedel, C Cui, KT Ho, HTJ Mount, JG Sled, KC Kain. PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria. PLoS Pathog (2014) 10(3):e1003980"]
["L243","P Pignatelli, R Carnevale, S Di Santo, S Bartimoccia, C Nocella, T Vicario, L Loffredo, F Angelico, F Violi. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation. Biochem Pharmacol (2012) 84(12):1635-1642"]
["L244","TN Kreis, KA McNeill, J Sul, FM Iwamoto, J Shih, HA Fine.  A phase I/II trial of vandetanib for patiens with recurrent malignant glioma. Neuro Oncol (2012) 14(12):1519–1526"]
["L245","DD Wang, DJ Englot, PA Garcia, MT Lawton, WL Young. Minocycline and tetracycline-class antibiotics are protective against partial seizures in vivo. Epilepsy Behav (2012) 24(3):314–318."]
["L246","CS Lin, CJ Cheng, CH Chou, SH Lin. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci (2007) 333(3):181-184"]
["L247","AG Herzog, P Klein, AR Jacobs. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology (1998) 50(3):782-784"]
["L248","AO Ogunmekan. Vitamin E deficiency and seizures in animals and man. Can J Neurol Sci (1979) 6(1):43-45"]
["L249","LN Ranganathan, S Ramaratnam. Vitamins for epilepsy. Cochrane Database Syst Rev (2005) (2):CD004304"]
["L250","J Dushay, C Gao, GS Gopalakrishnan, M Crawley, EK Mitten, E Wilker, J Mullington, E Maratos-Flier. Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes. Diabetes Care (2012) 35(1): 4-11"]
["L251","G Noll, RR Wenzel, S de Marchi, S Shaw, TF Lüscher. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation (1997) 95(9):2286-2292"]
["L252","M Nomura, K Uehara, K Harada, E Uemura, A Iga, T Kawano, A Nishikado, K Saito, Y Nakaya,  S Ito. Impairment of gastrointestinal motility by nitrate administration: evaluation based on electrogastrographic changes and autonomic nerve activity. Aliment Pharmacol Ther (2004) 20 (Suppl 1):118-124"]
["L253","DA Scheuer, SW Mifflin. Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol (2001) 280(5):R1440-1449"]
["L254","T Sithisarn, HS Bada, RJ Charnigo, SJ Legan, DC Randall. Effects of perinatal oxycodone exposure on the cardiovascular response to acute stress in male rats at weaning and in young adulthood. Front Physiol (2013) 4:85"]
["L255","B Ditzen, UM Nater, M Schaer, R La Marca, G Bodenmann, U Ehlert, M Heinrichs. Sex-specific effects of intranasal oxytocin on autonomic nervous system and emotional responses to couple conflict. Soc Cogn Affect Neurosci (2013) 8(8):897-902"]
["L256","D Kobayashi, M Takamura, H Murai, S Usui, T Ikeda, J Inomata, S Takashima, T Kato, H Furusho, Y Takeshita, T Ota, T Takamura, S Kaneko. Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with α-glucosidase inhibitor. Auton Neurosci (2010) 158(1-2):86-91"]
["L257","H Yokoe, F Yuasa, R Yuyama, K Murakawa,  Y Miyasaka, S Yoshida, S Tsujimoto, T Sugiura, T Iwasaka. Effect of pioglitazone on arterial baroreflex sensitivity and sympathetic nerve activity in patients with acute myocardial infarction and type 2 diabetes mellitus. J Cardiovasc Pharmacol (2012) 59(6):563-539"]
["L258","FE Gianiorio, M Casu, V Patrone, CG Egan, G Murialdo. Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes. Acta Diabetol (2011) 48(4):283-290"]
["L259","A Di Filippo, V Natale, F Del Po, M Ciapetti, Bressan F, Falchi S. Skin temperature during sympathetic block: a clinical comparison of bupivacaine 0.5% and ropivacaine 0.5% or 0.75%. Anaesth Intensive Care (2006) 34(3):334-337"]
["L260","T Bottiglieri. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule1–3. Am J Clin Nutr (2002) 76(suppl):1151S–117S"]
["L261","LH Price, DS Charney, GR Heninger. Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients. Psychopharmacology (1986) 89(1):38-44"]
["L262","B Silvestrini. Trazodone: from the mental pain to the \"dys-stress\" hypothesis of depression. Clin Neuropharmacol (1989) 12(Suppl 1):S4-S10"]
["L263","SD Kim, JK Park. Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms. Korean J Androl (2011) 29(2):91-100"]
["L264","DC Stump, DE Macfarlane. Clonidine and para-aminoclonidine, partial agonists for the alpha2-adrenergic receptor on intact human blood platelets. J Lab Clin Med (1983) 102(5):779-787"]
["L265","MP Ortega, MC García, MA Gijón, MF de Casa-Juana, JG Priego, M Sanchez Crespo, C Sunkel. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. J Pharmacol Exp Ther (1990) 255(1):28-33"]
["L266","P Hjemdahl, NH Wallen. Calcium antagonist treatment, sympathetic activity and platelet function. European Heart Journal (1997) 18 (Suppl A):A36-A50"]
["L267","S Theodoridou, M Economou, TA Vyzantiadis, A Teli, E Vlachaki, N Neokleous, A Kargioti, S Vakalopoulou, V Garypidou, N Gombakis, F Papachristou. Laboratory Investigation of Platelet Function in Patients with Thalassaemia. Acta Haematol (2014) 132(1):45-48"]
["L268","J Haselboeck, I Pabinger, C Ay, S Koder, S Panzer. Platelet activation and function during eltrombopag treatment in immune thrombocytopenia. Ann Hematol (2012) 91(1):109-113"]
["L269","K Freeman, S Farrow, A Schmaier, R Freedman,T Schork, W Lockette. Genetic polymorphism of the α2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens (1995) 8(9):863-869"]
["L270","T Nakagawa, H Hirakata, M Sato, K Nakamura, Y Hatano, T Nakamura, K Fukuda. Ketamine suppresses platelet aggregation possibly by suppressed inositol triphosphate formation and subsequent suppression of cytosolic calcium increase. Anesthesiology (2002) 96(5):1147-1152"]
["L271","Y Chang, TL Chen, GJ Wu, G Hsiao, MY Shen, KH Lin, DS Chou, CH Lin, JR Sheu. Mechanisms involved in the antiplatelet activity of ketamine in human platelets. J Biomed Sci (2004) 11(6):764-772"]
["L272","M Falciani, B Rinaldi, B D'Agostino, F Mazzeo, S Rossi, B Nobili, F Rossi, A Filippelli. Effects of nebivolol on human platelet aggregation. J Cardiovasc Pharmacol (2001) 38(6):922-929"]
["L273","J Rimal, SV Pisklakov, H Boules, A Patel. Acute Hyperkalemia and Hyponatremia Following Intraoperative Mannitol Administration. J Anesthe Clinic Res (2013) 4:294"]
["L274","M Nakasuji, M Nomura, M Yoshioka, T Miyata, N Imanaka, et al. Hypertonic Mannitol-Induced Hyperkalemia during Craniotomy. J Anesthe Clinic Res (2013) 4:299"]
["L275","JP Sharma, R Salhotra. Mannitol-induced intraoperative hyperkalemia, a little-known clinical entity. J Anaesthesiol Clin Pharmacol (2012) 28(4):546-547"]
["L276","J Liu, BB Gao, AC Clermont, P Blair, TJ Chilcote, S Sinha, R Flaumenhaft, EP Feener. Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nature Medicine (2011) 17:206–210 "]
["L277","R Schmidt, P Staats, DA Groneberg, U Wagner. Effect of montelukast on platelet activating factor- and tachykinin induced mucus secretion in the rat. Journal of Occupational Medicine and Toxicology (2008) 3:5"]
["L278","S Gupta, HM Wright. Nebivolol: A Highly Selective β1-Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide. Cardiovascular Therapeutics (2008) 26:189-202"]
["L279","DP Mikhailidis, V Fonseca, MA Barradas, RA Hutton, JY Jeremy, O Epstein, N McIntyre, P Dandona. Platelet aggregation and thromboxane A2 release in primary biliary cirrhosis and effect of D-penicillamine treatment. Prostaglandins Leukot Essent Fatty Acids (1988) 31(3):131-138"]
["L280","CF Opitz, R Ewert, W Kirch, D Pittrow. Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter? European Heart Journal (2008) 29:1936-1948 "]
["L281","HE Hamilton, RF Sheets. Sulfisoxazole-induced thrombocytopenic purpura. Immunologic mechanism as cause. JAMA (1978) 239(24):2586-2587"]
["L282","SS Sekhon,  V Roy. Thrombocytopenia in Adults: A Practical Approach to Evaluation and Management. Southern Medical Journal (2006) 99(5):491-498"]
["L283","G Nakhoul, A El Toukhy, J Simon. Tizanidine: A Cause of Hypokalemia. American Journal of Kidney Diseases (2012) 59(4):A60"]
["L284","MA Valentovic, WC Lubawy. Impact of Insulin or Tolbutamide Treatment on 14C-Arachidonic Acid Conversion to Prostacyclin and/or Thromboxane in Lungs, Aortas, and Platelets of Streptozotocin-induced Diabetic Rats. Diabetes (1983) 32:846-851"]
["L285","K Kawaguchi, Y Oribe, H Uzawa. Tolbutamide effect on cultured human endothelial cells with special reference to platelet aggregation. Tohoku J Exp Med (1983) 141(Suppl):563-568"]
["L286","JN George, RH Aster. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology (2009) 1:153-158"]
["L287","J Zeck, J Schallheim, SQ Lew, L DePalma. Whole Blood Platelet Aggregation and Release Reaction Testing in Uremic Patients. BioMed Research International Vol. 2013, Article ID 486290, 6 pages, http://dx.doi.org/10.1155/2013/486290"]
["L288","GE Linthorst, HJ Avis, M Levi. Uremic thrombocytopathy is not about urea. J Am Soc Nephrol (2010) 21(5):753-755"]
["L289","JS Kelloway. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma. Ann Pharmacother (1997) 31(9):1012-1021"]
["L290","TM Laidlaw, MS Kidder, N Bhattacharyya, W Xing, S Shen, GL Milne, MC Castells, H Chhay, JA Boyce. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood (2012) 119(16):3790-3798 "]
["L291","R Masunaga, A Nagasaka, A Nakai, M Kotake, Y Sawai, N Oda, T Mokuno, K Shimazaki, N Hayakawa, R Kato, E Hirano, M Hagiwara, H Hidaka. Alteration of platelet aggregation in patients with thyroid disorders. Metabolism (1997) 46(10):1128-1131"]
["L292","S Mamiya, M Hagiwara, S Inoue, H Hidaka. Thyroid hormones inhibit platelet function and myosin light chain kinase. J Biol Chem (1989) 264(15):8575-8579"]
["L293","GF Silveira, A Buffon, AN Bruno. New Approaches to Thyroid Hormones and Purinergic Signaling. Journal of Thyroid Research. Vol. 2013, Article ID 434727, 8 pages, http://dx.doi.org/10.1155/2013/434727"]
["L294","T Ichiki. Thyroid hormone and atherosclerosis. Vascul Pharmacol (2010) 52(3-4):151-156"]
["L295","MS Muntzel, EA Anderson, AK Johnson, AL MarkA L. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens (1995) 17(1-2):39-50"]
["L296","MF McCarty. Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes. Med Hypotheses(2004) 62(5):830-838"]
["L297","J Palace, J Newsom-Davis, BR Lecky. Myasthenia Gravis Study Group. A randomized double‐blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology (1998) 50(6):1778-1783"]
["L298","BM Conti-Fine, M Milani, HJ Kaminski. Myasthenia gravis: past, present, and future. J Clin Invest (2006) 116(11):2843–2854"]
["L299","JY Kim, KD Park, DP Richman. Treatment of Myasthenia Gravis Based on Its Immunopathogenesis. J Clin Neurol (2011) 7(4):173-183"]
["L300","H Moriya, S Kobayashi, T Ohtake, D Tutumi, Y Mochida, K Ishioka, M Oka, K Maesato, S Hidaka, S Nomura. Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect - a pilot study. Kidney Blood Press Res (2013) 37(2-3):190-198"]
["L301","PG Navarro, IH Blázquez, BQ Osso, PJM de las Parras a, MIM Puentedura, AAM Garcia. Penicillin degradation catalysed by Zn(II) ions in methanol. International Journal of Biological Macromolecules (2003) 33:159-166"]
["L302","X Li, H Li, S Li, F Zhu, DJ Kim, H Xie, Y Li, J Nadas, N Oi, TA Zykova, DH Yu, MH Lee, MO Kim, L Wang, W Ma, RA Lubet, AM Bode, Z Dong, Z Dong. Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B. Carcinogenesis (2012) 33(12):2548-2557"]
["L303","K Mangano, C Quattrocchi, C Aiello, G Scalia, A Speciale, G Nicoletti, R Di Marco. Immunomodulatory properties of cefaclor: in vivo effect on cytokine release and lymphoproliferative response in rats. J Chemother (2006) 18(6):641-647"]
["L304","DD Damasceno, AJ Ferreira,MC Doretto, AP Almeida. Anticonvulsant and antiarrhythmic effects of nifedipine in rats prone to audiogenic seizures. Braz J Med Biol Res (2012) 45(11):1060-1065"]
["L305","MJ Edelman, D Watson, X Wang, C Morrison, RA Kratzke, S Jewell, L Hodgson, AM Mauer, A Gajra, GA Masters, M Bedor, EE Vokes, MJ Green. Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203. Journal of Clinical Oncology (2008) 26(6):848-855"]
["L306","Z Meng, R Cao, Z Yang, T Liu, Y Wang, X Wang. Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin. Urology (2013) 82(6):1452.e7-14 "]
["L307","R Kato, K Ooi, M Ikura-Mori, Y Tsuchishita, H Hashimoto, H Yoshimura, K Uenishi, M Kawai, K Tanaka, K Ueno. Impairment of mycophenolate mofetil absorption by calcium polycarbophil. J Clin Pharmacol (2002) 42(11):1275-1280"]
["L308 ","M Morii, K Ueno, A Ogawa, R Kato, H Yoshimura, K Wada, H Hashimoto, M Takada, K Tanaka, T Nakatani, M Shibakawa. Impairment of mycophenolate mofetil absorption by iron ion. Clin Pharmacol Ther (2000) 68(6):613-616"]
["L309","RR Kulkarni, BK Bairy. Disulfiram-Induced De Novo Convulsions without Alcohol Challenge: Case Series and Review of Literature. Indian J Psychol Med (2015) 37(3):345-348"]